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Maternal death:  The death of a woman while pregnant or within 42 days of 
termination of pregnancy from any cause related to the pregnancy or its management, 
but not from accidental or incidental causes (ICD-10). 
 
Late maternal death: The death of a woman from direct or indirect obstetric causes, 
more than 42 days but less than one year after termination of a pregnancy.  
 
Pregnancy-related death: Death of a woman while pregnant or within 42 days of 
termination of pregnancy, irrespective of the cause of death.  
 
Neonatal death: The death of a live new-born during the first 28 days of life.  
 
Early neonatal death: The death of a live new-born during the first 7 days of life.  
 
Perinatal death: Foetal deaths occurring after 28 completed weeks of gestation, 
during childbirth and deaths of live new-born occurring up to 7 days of life.  
 
Results Based Financing:  Any program that rewards the delivery of one or more 
outputs or outcomes by one or more incentives, financial or otherwise, upon 

























The identification of policies and strategies that can increase coverage of 
pregnant women and the new-born with priority health interventions, especially for the 
poor, is one of the key challenges for global health. In the sub-Saharan Africa region, 
encouraging prospective mothers to deliver their babies in health facilities is one way 
of increasing coverage of skilled care at the time of delivery. In 2013, the Ministry of 
Health in Malawi embarked on an innovative initiative called Results-based financing 
for maternal and neonatal health (RBF4MNH) which provides conditional financial 
incentives to health workers to increase quality delivery care and to mothers for 
delivering in health facilities. Yet in the sub-Saharan region, the benefits of facility 
compared to home-based births; the impact of RBF initiatives on obstetric emergency 
care seeking and associated costs, and the evidence for RBF efficiencies are lacking.   
In this thesis, I conducted three separate studies. First, I examined maternal and 
perinatal benefits of facility-based births relative to home births. I conducted a literature 
review of population-based cohort studies reporting on maternal and perinatal outcomes 
by place of delivery in sub-Saharan Africa. The studies were assessed for quality using 
the Newcastle-Ottawa scale. I used meta-analytic procedures to summarise and describe 
the risks of maternal and perinatal deaths by place of delivery in the region. I identified 
nine (9) population-based cohort studies: 6 reporting on perinatal and 3 on maternal 
mortality. The mean quality score for the studies was high, averaging 10 out of 15 
points. A total of 36,772 pregnancy episodes were included in the analyses. Relative to 
facility births, perinatal mortality was higher among home births, but the difference was 
only significant when produced with a fixed effects model (OR 1.21, 95% CI: 1.02-
1.46) and not when produced by a random effects model (OR 1.21, 95% CI: 0.79-1.84). 
At best, 14 perinatal deaths might be averted per 1000 births if women delivered at 










There was increased risk of maternal mortality for facility-based relative to home 
deliveries (OR 2.29, 95% CI: 1.58-3.31).  
Second, using a pre-and post-design with independent controls, I used 
generalised linear models to ascertain the impact receipt of RBF4MNH had on time to 
seek care for women experiencing pregnancy related complications and associated 
household costs. I used primary household survey data conducted in four districts in 
Malawi:  at baseline in 2013 and repeated in 2014 (midline) and 2015 (endline), 
involving a total of 2, 219 women experiencing complications in their most recent 
pregnancy before the surveys. Receipt of RBF4MNH was associated with reduced 
expected mean time to presentation for facility care for women experiencing 
complications. The reduction in mean time till service was progressive: Relative to non-
RBF4MNH areas, time to seek care in RBF4MNH areas decreased by 27.3% (95% CI: 
28.4-25.9) at midline and 34.2% (95% CI: 37.8-30.4) at endline. Women with high 
education attainments, with more severe disease and high parity were more likely to 
present for care promptly. There was no demonstrable effect of RBF4MNH on overall 
(direct + indirect) household costs. However, women who received cash transfers as 
part of RBF4MNH had lower household costs, suggesting that receipt of cash may 
substitute informal carer’s time sufficiently to lower productivity losses/indirect costs 
and, ultimately, overall household costs.  
  Thirdly, I used a decision tree model, populated with both primary service use 
and cost data from Malawi and complimented with secondary epidemiologic data from 
the international literature, to estimate expected RBF4MNH efficiency in terms of cost 
per deaths averted and life years gained. Relative to the status quo, RBF4MNH cost 
$42.83 per additional birth, averted 0.0015 death and gained 0.0410 life year. Thus, 
RBF4MNH had an incremental cost-effectiveness ratio per death averted and life year 
gained of $29,135 and $1,045, respectively. At a willingness to pay of $1,446 (3 times 








The cost-effectiveness results were sensitive to assumptions about coverage of 
facility-based births in RBF supported facilities and share of women accessing quality 
care in control facilities. 
I conclude that policies that promote facility-based births can increase perinatal 
survival, but their benefits on material health would be contingent on concomitant 
quality improvement efforts given high risk of maternal deaths associated with facility 
deliveries in the SSA region. RBF encourages women with pregnancy related 
complication to present for facility care early which may lead to better outcomes if 
quality care is provided.  RBF appears borderline cost-effective at high levels of 
willingness to pay and unlikely to be cost-effective at less than 3 times GDP per capita. 
Countries should carefully consider overall RBF merits, at health system level, before 
introducing it as one of the strategies for increasing coverage of facility quality care to 
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CHAPTER 1: Introduction  
In this thesis, I present and discuss the findings of the economic analysis of a 
Results-based financing (RBF) initiative aimed at increasing service use and quality of 
maternal and perinatal healthcare at four districts in Malawi. I also present the 
implications of using RBF as an alternative option to fund maternal and perinatal 
healthcare in resource poor countries like Malawi. RBF is one of innovative health 
financing tools policy makers in developing countries are implementing to promote 
maternal and perinatal health by increasing the supply of and demand for quality 
facility-based care during childbirth. The evaluated RBF initiative is made of a supply 
side Performance based financing (PBF) and a demand side Conditional Cash Transfer 
(CCT) components. It was designed and is being implemented by the Reproductive 
Health Unit, Malawi Ministry of Health (MoH). 
While there is mounting enthusiasm for RBF among policy makers in developing 
countries, there are strong debates among academics and development partners related 
to whether RBF is the best way to finance healthcare services and improve health 
system performance in resource poor settings. These debates are indicative of important 
policy and research evidence gaps surrounding RBF. Through this work, I hope to 
generate valuable additional data to inform these debates. 
 1.1 Background to the research 
Coverage of pregnant women and new-borns with priority maternal and new-
born interventions in low income countries is generally low, with important disparities 
existing between income groups (United Nations 2010). As a result, it is estimated that 
in the sub-Saharan Africa (SSA) region alone in 2015, 1 million babies were stillborn 
(Blencowe, Cousens et al. 2016), about 0.8 million new-borns died within 7 days of 
birth (UNICEF 2015, Lawn J, Mongi P et al. 2015) while 201,000 women died from 
pregnancy and delivery complications (WHO 2015). The majority of these deaths could 
have been prevented if more mothers were provided with adequate prenatal and 
obstetric care (Bhutta, Darmstadt et al. 2005, Filippi, Ronsmans et al. 2006).  
Conventional mother and new-born health interventions that are effective, 




Although delivery of these interventions enabled several countries in the SSA region 
achieve Millennium Development Goals (MDGs) 4 (Child Mortality) and 5 (Maternal 
mortality) (UNDP 2015), maternal and perinatal mortality rates in the SSA region are 
still considered high, especially among populations most in need due to both 
constrained supply of quality care and sub optimal demand. To date, SSA has the 
highest maternal mortality ratio, 546 per 100,000 live births (WHO 2015) and perinatal 
mortality rate, 56 per 1,000 births (World Health Organization 2007).  Weak healthcare 
systems, lack of a skilled, motivated work force and inadequate finances limit supply 
of care (Prata, Passano et al. 2010, Prata, Passano et al. 2011); while poor quality care, 
direct and indirect costs associated with care seeking dissuade pregnant women from 
effectively demanding needed services (Borghi, Ensor et al. 2006, McNamee, Ternent 
et al. 2009).  
The traditional response by international agencies and donors to this state of 
affairs has been to significantly increase funding for maternal and new-born health 
(MNH) programs (Pitt, Greco et al. 2010). Referred to as input based aid, this support 
has largely focused on training of health workers, construction and upgrading of health 
facilities, purchases and distribution of new equipment and drug supplies (Hussein, 
Goodburn et al. 2001, Ameh, Msuya et al. 2012). Although some gains have been made, 
evidence shows that health systems in the sub-Saharan region continue to under provide 
effective MNH services, particularly for poor populations (Gauthier B 2006, Mbonye, 
Asimwe et al. 2007, Leigh, Mwale et al. 2008, Eichler, Agarwal et al. 2013). 
Lately, there have been calls for novel strategies that can significantly increase 
the supply of and demand for MNH interventions (Meessen, Soucat et al. 2011). To this 
end, several low and middle-income countries (LMIC), with technical and financial 
assistance from development partners, are piloting new healthcare financing strategies. 
Unlike input based aid, these strategies focus on health service outputs and are 
collectively referred to as Results-based financing (Musgrove 2011). 
Results-based financing (RBF) strategies are premised upon the assumption that 
individuals and organizations are motivated to perform better by incentives (Witter, 
Toonen et al. 2013). Within the context of MNH, RBF encompasses a range of 




financial rewards to encourage provision of quantity and quality care based upon 
attainment of pre-agreed targets. On the demand side, CCTs are designed to stimulate 
demand by lowering financial barriers to access care. This can be done by subsidizing 
transport and or stay in maternity waiting homes (Savedoff 2010, Morgan, Stanton et 
al. 2013). These financial incentives are also tied to autonomy, enhanced supervision 
and better data collection to allow for verification.  
As nearly half of all births take place at home and are conducted by informal 
health workers in the developing countries (Montagu, Yamey et al. 2011), RBF in the 
SSA region has often specifically focused on incentivizing the supply of or demand for 
quality facility-based deliveries (Basinga, Gertler et al. 2011, Bonfrer, Van de Poel et 
al. 2014, Binyaruka, Patouillard et al. 2015),  based on the recognition that mothers face 
the highest risk of death during birth (Orenstein, Orenstein et al. 2012). 
 1.2 Research gaps and justifications for the study 
As mentioned above, the rationale for investing in RBF within the context of 
maternal care hinges on its putative link with increased institutional service use and 
quality of care for mothers and new-borns in marginalized communities. Evaluation 
studies on impact of RBF schemes have therefore focused on output measures that are 
relevant for maternal and perinatal health.  
A number of reviews have summarized the current evidence base for RBF 
strategies (Fretheim, Witter et al. 2012, Eichler, Agarwal et al. 2013, Das, Gopalan et 
al. 2016, Turcotte-Tremblay, Spagnolo et al. 2016). Although individual RBF strategies 
are heterogeneous in terms of design and the rigor with which they are implemented, 
there is evidence that, under some favourable settings, RBF can increase coverage, 
quality and improve equity of access to MNH services (Morgan, Stanton et al. 2013, 
Das, Gopalan et al. 2016). However, most of these reviews highlight salient and 
important knowledge gaps some of which are the focus of this thesis.  
First, the health benefits of facility delivery relative to home births in developing 
settings are implicit, as no experimental trial which would allow for making of 
inferences about causality has been done (Nove, Berrington et al. 2012). The evidence 
used to promote facility deliveries usually is the graphical presentation of the inverse 




based deliveries. This evidence typically comes from ecological and/ or cross sectional 
studies (Scott and Ronsmans 2009, Moyer, Adanu et al. 2013, Godlonton and Okeke 
2016). Yet the intrinsic inability of such study designs to make causal inferences is well 
known (Scott and Ronsmans 2009). Reliable evidence from stronger study designs, 
such as cohort studies, that demonstrate the benefits of facility-based deliveries 
compared with home deliveries is thus required to better support and inform policies 
that advocate for institutional births in low income countries. 
Second, even though household costs and time to seek care are important 
dimensions of access to formal maternal care (Thaddeus and Maine 1994, Gabrysch and 
Campbell 2009)-with implications for maternal and perinatal health outcomes- few 
studies have described the impact of RBF on household costs (Soeters, Peerenboom et 
al. 2011) or on time  till service use for obstetric emergency  care in the SSA region.  
Dolan and Rudisill argue that context is important to understand health effects of any 
financial incentives (Dolan and Rudisill 2014). Therefore, evaluations of health 
outcomes would have greater explanatory value if they incorporate assessment of 
changes in other conditions that may modulate them i.e. through their actions on access 
(Thomson and Thomas 2015). Thus, understanding if and how RBF influences 
household costs and time to seek care might be helpful to explain changes in maternal 
and perinatal outcomes, or the lack of. Importantly, such understanding may also offer 
insight into potential policy and programmatic intervention points.  
Third, given that governments and their development partners have limited 
resources, RBF schemes compete for scarce funds with alternative strategies within the 
healthcare sector. It is therefore worth assessing whether RBF provides value for money 
(Borghi, Little et al. 2015). Currently, little information exists on cost-effectiveness of 
RBF schemes in the SSA region (Alfonso, Bishai et al. 2013) even though assessment 
of comparative efficiency  of RBF schemes has been identified as a priority research 
area (Eichler, Agarwal et al. 2013, Mangham-Jefferies, Pitt et al. 2014, Turcotte-
Tremblay, Spagnolo et al. 2016). Cost-effectiveness information will add to regional 
evidence on RBF, thereby supporting policy makers prioritize health interventions and 





1.3 Research questions  
Commensurate with the identified research gaps, the thesis sets to answer three 
questions: 
o What are the risks of maternal and perinatal mortality for facility-based 
deliveries compared with home-based deliveries in sub-Saharan Africa? 
o What effect does RBF have on household costs and time to seek facility care 
for women experiencing pregnancy related complications?  
o What is the cost-effectiveness of obstetric care under RBF compared with 
status quo care? 
1.4 Methodological approach 
Answering all the three questions would not have been possible using a single 
method alone. A mix of non-empirical and empirical approaches was therefore used.  
This strategy allowed graded generation of data that informed design and conduct of 
subsequent approaches and ultimately allowing all the three questions to be answered. 
A literature review and meta-analysis of population-based cohort studies in SSA 
allowed the quantification of the risk of maternal and perinatal mortality by place of 
delivery. Three waves of cross-sectional household data allowed the estimation of 
effects of RBF on household costs and time to seek care for women experiencing 
complications. In particular, this line of inquiry offered insight regarding the extent to 
which financial incentives may contribute to timely emergency care seeking and thus 
ultimately reduce maternal and perinatal mortality in beneficiary populations. A 
decision tree model enabled estimation of the expected mean costs and expected health 
benefits of RBF relative to status quo care. These assessments were supplemented with 
a review of Malawi RBF project documents and Health Information System data.  
1.5 Situating the thesis  
During the period of the thesis, I was based at the Centre for International Health, 
University of Bergen, Norway. However, this PhD -and several other related research 
projects-was situated within a community-based RBF for maternal and neonatal health 
(RBF4MNH) study in four districts- Balaka, Ntcheu, Mchinji and Dedza- in Malawi. 
The RBF4MNH study was evaluating the programmatic piloting   RBF in Malawi. The 




uptake and quality of maternal and perinatal care at mainly public health facilities 
designated as capable of providing emergency obstetric care (EmOC) services by the 
Malawi MoH. All primary data collection for this PhD thesis was based on the four 
study districts in Malawi.  
1.6 Organization of the thesis 
The rest of the thesis is organized as follows. Chapter two provides the 
definitions, key concepts and terminologies around RBF. In addition, it provides a brief 
description of the principal agent theory whose constructs underpin analyses of task 
delegations and contracting within the healthcare system. Chapter three situates the 
thesis within the context of the broader published literature on RBF. Chapter four 
situates the thesis within the specific environment in Malawi. It highlights both the 
economic background and policy developments related to reproductive healthcare in 
the country with focus on maternal and new-born health. Chapter 5 outlines the thesis 
general and specific objectives. Chapter 6 describes the methods used to achieve the 
three thesis objectives. Chapters 7, 8 and 9 present the results of the three studies. 
Finally, Chapter 10 presents key findings, recommendations and conclusion. 
CHAPTER  2: Theoretical frameworks 
This chapter is divided into three sections. Section 2.1 provides an overview of 
key dimensions that are used to measure health intervention performance. Section 2.2   
provides a brief introduction to RBF and defines its related key terminologies.  Section 
2.3 describes the theoretical basis underlying RBF and generates a conceptual 
framework illustrating how RBF implementation may lead to improved maternal and 
perinatal health outcomes. Section 2.4 provides an overview of costing approaches for 
healthcare programs. Finally, section 2.5 provides a general framework for cost-
effectiveness analysis, illustrating how health outcomes and costs are linked and 
interpreted in economic evaluations.  
2.1 How is the performance of a healthcare intervention measured? 
Von Bertalanffy defines a system as an arrangement of parts and their 
interconnections that come together for a purpose (Von Bertalanffy 1968). Thus, by 




including health providers, individual patients, their households and communities-
whose primary purpose is to produce health (The World Health Report 2000). 
Because a healthcare intervention is an integral part of a health system, the 
domains used to measure its performance are similar to those used for assessing health 
system performance, see for example: (Kessner, Kalk et al. 1973, WHO 2000, Handler 
A, Issel M et al. 2001).  
The following sections describe concepts that specifically relate to measuring 
performance of a healthcare intervention (such as an RBF initiative), including 
effectiveness, quality, equity and efficiency. The three thesis objectives to varying 
degree align with these outlined concepts. For example, objective 2 is concerned with 
effectiveness (described in section 2.1.1) whereas objective 3 is concerned with 
efficiency (described in section 2.1.4).  
2.1.1 Effectiveness 
Several definitions for the term effectiveness exist. The one probably most 
pertinent to appraisal of healthcare interventions  is that proposed by Wojtczak which 
states that effectiveness is a measure of the extent to which a specific intervention, 
procedure, regimen, or service, when deployed in the field in routine circumstances, 
does what it is intended to do for a specified population (Wojtczak 2012). In the public 
health field, effectiveness is often measured using intermediate indicators e.g. coverage, 
access and quality. 
Coverage and access are themselves related concepts, though each has unique 
connotations. Among public health policy makers, there is some debate whether 
coverage is a means to an end or an end in itself (McManus J 2013). It can be argued 
that the World Health Organization-through the concept of universal coverage-treats 
coverage as an end; setting it as a goal  that individuals  obtain the interventions they 
need without risking financial hardship from unaffordable out-of-pocket payments 
(World Health Organization 2010). This goal recognizes coverage with health services 
as well as coverage with a form of financial risk protection.  
Regarding access, different constructs exist. The construct used here is a more 
recent one  proposed by McIntyre et al and is based on three interacting dimensions: 




is understood as the presence of good health services within reasonable reach of those 
who need them and of opening hours, appointment systems and other aspects of service 
organization and delivery that allow people to obtain services as needed. Affordability 
relates to people’s ability to pay for services without financial hardship. It considers not 
only the price of the health services, but also direct and indirect costs associated with 
obtaining the care. As such, affordability is influenced by the wider health financing 
system and by household income. Acceptability relates to people’s willingness to seek 
services. It is influenced by social and cultural factors as well as perceptions of service 
effectiveness and quality (Evans, Hsu et al. 2013).  
2.1.2 Quality 
Quality is inextricably linked to effectiveness and has various but related 
definitions. An earlier definition by the American Institute of Medicine describes 
quality as the "degree to which health services for individuals and populations increase 
the likelihood of attaining desired health outcomes and are consistent with current 
professional knowledge" (Lohr K 1990) whereas the World Health Organization 
defines quality as “the process of meeting the needs and expectations of patients and 
health service staff.” Donabedian, the father of healthcare quality,  suggested a broader 
definition of  quality care with three key dimensions: structural, process and outcomes 
(Donabedian 1966). The structural dimension is contextual and relates to such things as 
range of services provided, staff cadres and other means of health production e.g. drugs 
and supplies. The process dimension refers to how care is delivered and covers all the 
actions that encompass healthcare delivery. The outcome dimension relates to the 
effects and results of the care delivered. Like effectiveness, it refers to changes in health 
status because of treatment or intervention. 
2.1.3 Equity 
Equity in health is a normative concept and could denote all types of differences 
between individuals and groups.  Commonly, equity is considered as denoting the 
absence of avoidable or remediable differences among groups of people (Whitehead M 
1992). Health inequalities are thus considered unfair and inequitable because they do 




beyond an individual’s control. Health inequalities that are rooted in political and social 
decisions (in contrast to biological or genetic differences) are also considered avoidable. 
This notion is consistent with the operational proposition by Braveman that a health 
inequality is a particular type of difference in health or in the determinants of health that 
could potentially be shaped by policies i.e. a difference in which disadvantaged social 
groups-such as the poor or less educated-systematically experience worse health or 
greater health risks than more advantaged social groups (Braveman 2006). Social 
economic status (SES) or groups are often classified according to individuals wealth 
index, based on housing characteristics and assets ownerships (Vyas and 
Kumaranayake 2006). Although equal treatment for equal need is a principle often 
proclaimed in health policy, the bulk of studies report consistent variations in both 
treatment and outcomes by SES (Wilder-Smith 2003, Ahmed, Creanga et al. 2010).  
2.1.4 Efficiency 
Efficiency is an economic term and considers resource use when measuring 
intervention’s performance. Technical efficiency is achieved when allocation is 
organized to minimize the inputs required to produce a given output; and allocative 
efficiency is achieved when allocation is organized in a way that the prices of each good 
produced are proportional to the utilities consumers derive from them (McPake  B and 
Normand C 2008, page 28). 
2.2 Results-based financing 
Achieving best results from a health system depends on choosing an optimal mix 
of health system components that offer the best value, and making sure they are  
implemented in the most efficient way (Drummond MF, Sculpher MJ et al. 2005, page 
7). In practice, Eichler et al. point out that conflicting mandates and sometimes perverse 
incentives can stand between how a component of a health system e.g. treatment 
program is implemented by healthcare providers and results obtained by consumers of 
the healthcare. For example, a health program design may not contain explicit 
incentives for efficiency or offer few incentives for effectiveness. To optimize 
intervention performance (however it is measured), there is need to ensure congruity 




that one approach that can be used to align disparate objectives in the healthcare sector 
in order to get better results (or health) is Results-based financing (Preker, Harding et 
al. 2000, Vujicic M 2009). 
2.2.1 What is results-based financing? 
Programs that link rewards (financial or material) conditional on performance 
are collectively called results based (Musgrove 2011). The term RBF encompasses a 
range of mechanisms and a spectrum of design, implementation and financing options 
(Oxman and Fretheim 2009). In the healthcare sector, RBF programs are not new. 
Developed countries such as the United Kingdom and the United States have all 
provided financial rewards to hospitals, healthcare providers and insurers for meeting 
volume and quality targets (Campbell, Reeves et al. 2007). The economic downturn in 
high-income economies has led to a period of stagnating, reduced aid to developing 
countries and subsequent falling budgets for global health (Fan, Duran et al. 2013). 
Consequently, international efforts to improve health in developing countries are also 
increasingly exploring initiatives such as RBF to increase volume and quality of 
healthcare (Meessen, Soucat et al. 2011).  
2.2.2 Results-based financing related key concepts 
RBF is an umbrella term and is often used interchangeably with related concepts 
such as performance-based financing (PBF), Performance based contracting (PBC), 
contracting out or purchasing health services. Although the growing attention and 
experimentation with RBF has led to increasing clarity about its main features regarding 
designs and implementation options (Savedoff 2010), some confusion about the terms 
still exists.  The World Bank has created a glossary of terms to help make clear the 










Table 1: Results-based financing related concepts, activities, targets and example 
Concept Activities Target Examples  
Performance based 
Financing (PBF) 
Financial rewards given to health 
workers providing a list of 
services, conditional on pre–agreed 
targets.  
Typically, the public health sector at   
health facility or health worker/ 
management team level. 
Basinga et al. 2011; 
Binyaruka et al. 
2015; 
Results based budgeting 
(RBB) 
Budget payments based on desired 
outputs 
Sub-national administrations, zones 
or public-sector organizations 
Brenzel et al 2009 
Brenzel et al 2015; 
Conditional cash transfers 
(CCT) 
Financial rewards given to 
consumers upon use of a social 
service. 
Geographical area, vulnerable groups 
such as children or mothers and other 
users of services 
Lim et al 2010; 




Payment for a set of social services 
purchased from or contracted out 
to non-governmental organization 
(NGO) or contracted in, in the 
form of technical support, to public 
facilities.  
Depending on context, targets can be 
individual health facilities, districts or 
provinces 
Loevinsohn 2009 
Health Equity funds (HEF) Payment for priority health 
services for the poor  
The poor and vulnerable individuals 
so they are cushioned from 
catastrophic health expenditures  
Ir et al. 2010; 
Cash on delivery aid (COD 
aid) 
Payment is for achieving pre-
determined results. 
Government Birdsall et al. 2010; 
Output based aid (OBA) Developmental aid based on output 
not input. 
Diverse social or utility service 
providers such as education and 
energy 
Mumssen et al. 2010; 
Vouchers  Payment to providers and or 
consumer of healthcare 
Providers and specific clients or 
individual to reduce\remove cost at 
point of use 
Ahmed et al.   2011; 
Nguyen et al.  2012; 
Alfonso et al.  2014; 
 
Source: Adapted from Musgrove, 2011 
2.2.3 Results-based financing main categories 
Pearson posits that the purpose of RBF is to transfer purchasing power to 
specified groups for the purchase of defined goods or services (Pearson M 2001). In this 
regard, RBF schemes can further be categorized into supply–side and demand-side, 
depending on where the financial transfers are primarily applied. Although in practice 
this categorization is not clear as cut, Figure 1, it still is useful in understanding the 
design of individual RBF schemes, the potential beneficiaries they aim to target and 






































































































































































































































































































2.3 Theoretical foundations for Results based financing 
To understand how RBF, in particular supply side PBF schemes, may lead to 
better health, it is first important to understand what governs contractual relationships. 
Below, the theoretical basis underpinning PBF is outlined.  
2.3.1 Principal Agent Theory 
Conrad argues that  the principal agent theory is suited to  explain contractual 
and other economic relationship where one individual (principal) delegates or contracts 
tasks to another individual (agent) (Conrad 2015). In this relationship, the principal has 
objectives she wants to attain but may not have the capacity in terms of skills to achieve 
them. Information asymmetry between the two often entails that the principal cannot 
directly observe or may not know the level of technical skills expended by the agent 
doing the contracted work (Ross 1973, Witter, Fretheim et al. 2012). When the principal 
is not certain about the production process or when the transactional costs of monitoring 
the agent are higher than the costs of monitoring outputs, it may be better to pay the 
agent on the basis of pre-specified performance and targets (Savedoff 2010).  
Pertaining to healthcare, the principal serves as a purchaser, providing both 
financing and oversight, with an objective of increasing health system performance-
such as effectiveness, efficiency and equity. The function of the agent in this 
relationship is to provide healthcare according to standards stipulated in the contract 
(Liu, Hotchkiss et al. 2007). In the specific context of RBF4MNH, this means the 
Ministry of health (the principal) paying providers of healthcare (the agents) for 
delivering women in a health facility or the Ministry of health paying mothers (agents) 
for delivering in health facilities. 
According to Conrad, the principal seeks to design payment structures that 
induce the agent  to deliver the quantity and quality of service that will provide value 
for money (Conrad 2015). In practice, both the principal and  agents may manifest 
opportunistic behaviours (Preker, Harding et al. 2000); contractual obligations may thus 
have both intended and unintended effects. The principal-agent model is robust enough 
to provide insight into potential adverse consequences or opportunistic behaviours that 
may arise, for example, due to fraud or gaming. This may occur, for example, when 




put their focus on incentivized services to the detriment of other (but equally important) 
un-incentivized services, or select simple to manage, less costly patients (Shen 2003, 
Savedoff 2010). 
2.3.2 How do financial incentives work? 
An important aspect of the study of any financial incentives is the understanding 
of the mechanism or pathways through which they may effect change(s).  Uri et al, 
suggest that financial incentives act in two ways, though the standard direct price effect 
by making the incentivized behaviour more attractive and indirectly through 
psychological effect (Uri Gneezy, Stephan Meier et al. 2011). The subsections below 
describe how these theoretical perspectives are applied in the healthcare sector through 
both the demand and supply components of RBF to increase service use and quality of 
care, respectively.  
2.3.2.1 How demand side financial incentives may effect change in 
service use 
Recognising the importance social-economic constraints place on poor families 
in accessing and utilizing healthcare, financial rewards are designed to encourage poor 
families to invest in their health. Financial incentives, if large or frequent enough, can 
increase incomes. It is assumed that more income would enable poor families to 
overcome economic barriers that constrain their access to healthcare, leading to 
increased expenditures on (or consumption of) normal goods such as healthcare for 
pregnant mothers or new-born infants. In this regard, the financial incentives are 
anticipated to change behaviour through income effect as predicted by economic theory 
(De Walque, Dow et al. 2012).  
Conditional incentives can also be used to increase demand through price effect.  
While standard economic theory postulates that fully informed individuals make 
rational decisions after weighing the advantages and disadvantages of different choices, 
in reality, inconsistencies exist between economic models and human rationality 
(Higgins 2010, Heise, Lutz et al. 2013). For example, individuals or households may 
overestimate the price of effective preventive interventions for addressing health 
problems such as antenatal screening, leading to sub-optimal utilization, with potential 




the unborn child at risk. Alternatively, private investment in new-born’s human capital 
can be  too low due to parents incorrectly believing that future earnings respond to 
health investments less elastically than is actually the case (Ariel Fiszbein, Norbert 
Schady et al. 2009). By conditioning financial rewards on healthcare utilization, the 
financial rewards can be used to stimulate households to act towards appropriate health 
seeking behaviours such as antenatal care screening or facility deliveries. 
2.3.2.2 How supply side financial incentives may effect change in 
quantity of care 
The same reasoning as outlined above is applicable to providers of healthcare. 
According to Prendergast, providers obtain utility from net income and disutility from 
efforts exerted on behalf of the principal (Prendargast C 1999). Therefore, by making 
financial incentives contingent on volume of units of services provided, the financial 
rewards can be used to shape provider behaviour leading to increased quantity of 
provided health services. In these aspects, conditioning acts through the price effect 
mechanism: a “price” is incurred (loss of a financial reward) if a particular behaviour 
or task is not performed (De Walque, Dow et al. 2012). 
2.4 Conceptual framework for evaluating impact of results-based 
financing on maternal and perinatal health outcomes.  
Based on the above discussions and drawing on the ideas by Glassman et al 
(Glassman, Duran et al. 2013) together with works by Witter et al (Witter, Toonen et 
al. 2013) and Brenner et al (Brenner, Muula et al. 2014) this section presents an intuitive 
conceptual framework within which to evaluate the impact of RBF on maternal and 
perinatal mortality as shown in Figure 2. 
I assume that offering health providers conditional financial incentives, linked to 
quality facility based care for pregnant mothers, can motivate them to increase the 
supply of priority maternal services (Diamond and Kaul 2009) or to stimulate a change 
in their behaviour so that they comply more with clinical guidelines with respect to 
preventive, diagnostic and treatment decisions (Epstein, Lee et al. 2004); then, I can 
anticipate that the mothers and infants they treat should (by definition) receive quality 
care (Campbell, Roland et al. 2000). I also anticipate that the conditional financial 




increased demand for facility-based deliveries. Or, alternatively, that the financial 
incentives would increase poor mothers’ income, enabling them to overcome economic 
barriers to accessing pregnancy related care and thus reducing inequality in access. The 
combination of increased supply of quality care by providers and increased use of 
quality care by vulnerable mothers and their new-born infants should lead to reduced 
frequency or severity of maternal and new-born illnesses. These improvements in health 
outputs should be reflected by a corresponding reduction in maternal and perinatal 
mortality, respectively, at population level. In making this postulation, I am cognizant 
of the fact that demographic factors (e.g. age and number of previous pregnancies) and 
social economic factors (e.g. wealth and education status) can also positively or 





Figure 2 : Proposed conceptual framework for assessing the impact of Results-based financing on 
maternal and perinatal mortality.  
This figure assumes that demand and supply measures are applied jointly, which is consistent with the 
RBF configuration in Malawi. However, this is not always the case.  
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2.5 Costing of healthcare interventions 
2.5.1 Costs 
Costs are values of resources needed to provide a service. Healthcare costs are 
thus estimated by identifying and quantifying resources that are consumed during the 
course of providing care and then assigning monitory values or prices to each resource 
(WHO 2003). Different ways have been proposed to categorize costs. Drummond et al 
categorize costs into two: a) Direct costs such costs of medical care (including the 
intervention itself and follow-up care) and the cost of traveling to and from a health 
facility b) Indirect costs such as the value of time that family and informal carers’  spend 
seeking care and  caring for  patients, and  the value of the patients’ time in treatment 
(Drummond MF, Sculpher MJ et al. 2005, page 24). Costs in addition can be 
categorized into fixed and variable costs (Shepard, Zeng et al. 2015). Fixed costs are 
those that do not change as volume of care increases. Examples include office rentals 
and insurance. Variable costs are those that change with volume of care, they include 
drugs and other consumables. A third way to categorize costs is into financial and 
economic costs. Financial costs focus on direct expenditures (Creese A and Parker D 
1994). Unlike financial costs, economic costs reflect on what is forgone (opportunity 
costs) in terms of benefits elsewhere, because funds are tied up to provide the 
intervention being evaluated (Drummond, O'Brien et al. 1997, page 54, WHO 2003) 
2.5.2 Approaches to costing 
Two approaches are often used to collect and measure cost information (Shepard, 
Zeng et al. 2015). The macro-costing approach uses summary expenditure data e.g. 
based on administrative records and allocate them to a health program based on proxy 
allocation factors such as percentage of space use or share of consultations. Though not 
as precise, this approach is time saving (Drummond MF, Sculpher MJ et al. 2005, page 
78).  Micro-costing on the other hand uses detailed information based on types and 
quantity of inputs e.g. from surveys and inventory records. Micro-costing requires more 
time, relative to macro costing, but provides more detailed cost information about 





The costs that are most appropriate for inclusion in an analysis depend on its 
“perspective.” The term “perspective,” when used in economic analyses, refers to 
whose costs are counted and, thus, to what is quantified. Providers (health systems) and 
patients (household) perspectives are commonly used. The most comprehensive 
perspective is that of society, which includes all costs but not necessarily all financial 
transactions, on all levels attributable to an illness’s impact and treatment (Polsky, 
Doshi et al. 2006). Taking into consideration the different perspectives is helpful not 
just in providing as much detail as possible, but also in allowing for the presentation of 
results to different audiences.  
2.5.4 Time horizon 
Economic analyses ideally should be long enough to capture all the differences 
in health outcome and cost between alternative interventions that are likely to have an 
impact on the results (Gray, Clarke et al. 2011, page 73). Glassman et al  argue that this 
is especially pertinent to incentive based interventions,  as providers and clients may 
adapt to incentive structures, leading to time varying outcomes and costs (Glassman, 
Duran et al. 2013).  
2.5.5 Discounting 
Individuals and society prefer to have dollars or resources now as opposed to 
later because they can benefit from them in the interim (Hauck, Smith et al. 2004). To 
allow for this time preference, it is recommended that future costs should be discounted 
so that an amount paid in future is assigned a lower value than the same amount paid in 
the present. Future costs are first expressed in constant prices or present value of the 
year in which the program started and then discounted. An overall indicator of inflation, 
the Gross Domestic Product (GDP) deflator is often chosen to convert future costs into 
constant costs (Shepard, Zeng et al. 2015). A common discount rate of 3% (WHO 2003) 
is then applied to costs incurred during different years. 
While there is consensus on discounting of costs, discounting of health benefits/ 
outcomes is one of the most controversial issues within health economics practice with 




MJ et al. 2005, page 109). In keeping with WHO recommendation, a discount rate of 3 
% will be used to discount outcomes in this study (WHO 2003).  
2.6 Economic evaluations: Normative basis 
Tsuchiya and Williams argue that economic evaluations are built upon classical 
welfare and extra welfare economics frameworks (Tsuchiya and Williams 2001). The 
classical welfare framework focuses on individual utility or preferences.  A situation in 
which the sum of utilities is maximized is judged to be optimal. This necessitates that 
utilities are measured in a cardinal scale to allow for comparison of absolute utility 
levels obtained by different individuals. As indicated by Hauck et al attaining such 
utility properties historically was considered unattainable, leading  to replacement of 
utility maximization criterion by the concept of Pareto optimality (Hauck, Smith et al. 
2004). A situation is judged Pareto optimal when a utility distribution strategy or social 
policy exists where one party's situation cannot be improved without making another 
party's situation worse. Although considered both technically and allocatively efficient 
(Kaldor 1939) and (Hicks 1939) argue that  in practice, it is almost impossible to take 
any social action without making at least one person worse off. To overcome this, they 
proposed the concept of Pareto improvement, this entails that individuals that are made 
better off following a social policy can compensate those that are made worse off and 
remain in preferred position compared with the situation before the policy change (the 
Kaldor-Hicks criterion).  
It has been argued that extra-welfarism was developed to adapt the classical 
welfare economic framework to the particular characteristics of priority setting for 
health (Sen A 1995, Hauck, Smith et al. 2004); that is,  this  non-welfarist perspective 
takes an exogenously defined societal objective and budget constraint for healthcare 
(Briggs A, Claxton K et al. 2006, page 3). This position is relevant to this study, as the 
focus of the RBF4MNH intervention is on maximizing maternal and perinatal health 
outcomes within a fixed budget.  
2.6.1 Types of economic evaluations  
According to Drummond et al there are four main types of full economic 




analysis and d) cost minimization analysis (Drummond MF, Sculpher MJ et al. 2005, 
page 11). The different types of evaluation methods serve different purposes. The 
objective of cost-benefit analysis is to maximize net benefits, while the objective of cost 
effectiveness analysis is to rank order the preferred alternatives for maximizing 
achievement of health. Cost-utility analysis (CUA) allows more complex measures of 
consequences, which can be compared over different types of interventions. The 
selection of the appropriate analytic method depends on many factors, including the 
target audience for the study, the study question, and the availability of data. This thesis 
aims to inform policy about how RBF compares with current practices for increasing 
social welfare through maternal and perinatal health promotion, and a CUA would have 
been appropriate for the purpose. Due lack of data to inform calculations of Quality 
Adjusted Life Years (QALYs), however, I rather conducted a cost-effeteness analysis 
(CEA) based on mortality data and calculations of life years gained. 
2.6.2 Cost effectiveness analysis  
CEA compares interventions in terms of both health outcomes and costs. The 
intervention under study can be compared, for example, to the option of “doing 
nothing,” to “minimum care,” to “usual care,” or the highest valued alternative 
intervention. Although a randomized trial data under routine setting is the best source 
of evidence for a program effectiveness, information on program intermediate 
indicators such as coverage and quality can  also be used to estimate program effects as 
long as such indicators have clinical utility (Drummond MF, Sculpher MJ et al. 2005, 
page 108).  
 
2.6.3 The incremental cost effectiveness ratio  
 
The central measure in CEA is the incremental cost-effectiveness ratio (ICER) 
(Gold et al. 1996b). The ICER is the difference in costs between two interventions 
divided by the difference in their effects, and is interpreted as the incremental price of 
a unit health effect from the intervention under study, relative to the other (Hauck, Smith 








A represents old intervention, B represents new intervention while ∆𝐶 and ∆𝐸 represent the 
difference between costs and effects of the two interventions, respectively.  
Figure 3 illustrates that to inform decisions, CEA results should enable policy 
makers identify interventions that are less costly than the comparator and have better 
health outcomes, called dominant, and preclude those that are costlier and less effective, 
termed dominated. Interventions that are less costly and less effective relative to 
comparators or interventions that are more costly and more effective compared with 
comparators are selected if they are considered good value for money (Drummond, 
O'Brien et al. 1997, page 40) . 
 
Figure 3 : Schema for interpretation of cost-effectiveness analysis results. 
The dotted line shows a given willingness to pay (WP) threshold. If an intervention’s ICER lies above the line, it 
is not acceptable on cost-effectiveness grounds. Either it is dominated by the alternative, whatever the WP 
threshold, as in point a; or its ICER does not satisfy the WP, as in points c and d.  In the north-east quadrant, this 
means that the ICER is above the WP level, as in point c; the higher benefits are outweighed by the higher costs.  In 
the south-west quadrant, as in point d; the cost saving does not justify the lower effectiveness. Below the WP 
threshold the intervention is acceptable. This is because either it dominates the alternative, as in point b, or its 
ICER satisfies the WP level, as in points e and f. If the ICER is below the WP line in the north-east quadrant, as 
in point f, the higher costs are justified by the increased benefits.  If it is below in the south-west quadrant, as in 
point e, the cost savings outweigh the lower benefits.  





2.6.4 Cost-effectiveness thresholds 
Which value is low enough for the intervention to be chosen is a subjective decision, 
depending ultimately on the value society places on a unit of health effect. When 
DALYs are used as health outcomes, the GDP per capita has been suggested as a 
threshold to determine if an intervention being evaluated is cost-effective or not, relative 
to a comparator. An intervention is considered highly cost-effective if its ICER is less 
than GDP per capita; cost-effective  if the ICER is between one and three times GDP 
per capita; and not cost-effective  if the ICER is more than three times GDP per capita 
(WHO 2001). Although Malawi has no official policy on what threshold to use, local 
documents cite cost-effectives as defined above as one criteria for selecting priority 
interventions and services (Bowie and Mwase 2011, MoH 2011). The use of the WHO 
proposed threshold can thus be considered pertinent in this thesis. Additionally, this 
would be in keeping with international economic studies on RBF (Alfonso, Bishai et al. 
2013) allowing for comparison of this thesis results with published data.  
However, others have criticized this decision rule (Revill, Walker et al. 2014, 
Marseille, Larson et al. 2015). Using GDP per capita as a threshold does not necessarily 
ensure that a new intervention is affordable. Importantly, Marseille et al argue that using 
GDP per capita as the threshold is premised on an assumption that the country is willing 
to pay up to that threshold for the health benefit (Marseille, Larson et al. 2015). Often 
concrete evidence of that willingness to pay is not available. Revill et al further argue 
that, especially for developing countries where coverage gaps remain for other 
important health interventions, implementing any new costly  intervention according to 
this criterion can only occur at the expense of other interventions being replaced (Revill, 
Walker et al. 2014). If the intervention being pushed out has higher benefits, this may 
lead to overall health loss at a health systems level and may risk causing inequalities.  
2.6.5 Uncertainty analysis 
It is recognized that outcomes from trials suffer from sampling errors and there 
are uncertainties related to selection of trials to inform parameter estimates in CEA. In 
addition, when CEA is based on modeling,  some uncertainties are structural, meaning 




al. 2006, page 83). It is thus recommended to systematically document these 
uncertainties by conducting sensitivity analyses (Briggs and Gray 1999). Two 
approaches are often used when performing sensitivity analyses to characterize these 
uncertainties. 
2.6.5.1 Deterministic sensitivity analysis  
In deterministic sensitivity analysis, single-point parameter estimates are used 
(Briggs, Sculpher et al. 1994). The estimates are chosen to reflect values for discreet 
scenarios such as worst case, best case and most likely case. Because it considers one 
or two parameters at a time, deterministic sensitivity analysis faces criticism that it is 
over simplistic. Examples of deterministic sensitivity analysis include one way, 
threshold and scenario analyses.  
2.6.5.2 Stochastic sensitivity analysis 
In stochastic sensitivity analysis, parameter uncertainty is incorporated by using 
ranges of probable values or probability distributions (Briggs, Sculpher et al. 1994).  
Using probability distributions instead of single point parameter estimate is considered 
a more realistic way of describing uncertainties, since the method enables simultaneous 
consideration of uncertainty in many parameters. Stochastic sensitivity analysis, also 
called probabilistic sensitivity analysis (PSA) are commonly done through 
bootstrapping and the results presented as cost–effectiveness acceptability curves, 
scatter plots and expected value of perfect information results (Gray, Clarke et al. 2011, 
page 279). 
Cost effectiveness acceptability curves represent uncertainties for an 
intervention over a range of thresholds for cost-effectiveness (Briggs A, Claxton K et 
al. 2006, page 167). Thus, for any given value of willingness to pay for a health 
outcome, acceptability curves show the probability of an intervention being cost-
effective relative to its comparator. Cost effectiveness scatter plots on the other hand 
plots the uncertainty in the costs and effects associated with an intervention as simulated 
incremental cost and effect pairs in a cost-effectiveness plane.  Finally, expected value 
of perfect information are premised on the fact that there is a chance a wrong decision 




associated with some degree of uncertainty. The expected cost of this uncertainty can 
be estimated by calculating the joint probability of  making a wrong decision and the 
expected costs of making that decision (Briggs A, Claxton K et al. 2006, page 170). 
2.7 Summary  
Dimensions for measuring health intervention performance have been described 
in this chapter. RBF schemes and related concepts have also been explained. This 
information is useful for understanding evaluation studies of RBF schemes reviewed in 
the following Chapter. This chapter also presented a framework depicting how RBF 
may lead to better health outcomes and another guiding the conduct of an RBF cost-
effectiveness analysis, both are relevant for understanding results of studies II and III 
presented in chapters 8 and 9, respectively.   
CHAPTER 3: Literature review 
This Chapter reviews evidence from the published literature related to RBF 
schemes’ effects. To obtain the information, Medline database was searched using the 
terms “results-based financing”, results based financing and “rbf” combined with 
“impact” or “effects”. The search inclusion criteria was broad enough to include studies 
done in countries classified as low and middle income countries (The World Bank) 
irrespective of year of publication but limited to publications in the English language. 
Additional studies, including the grey literature, were identified through searches of 
reference lists. The search was repeated with one additional restriction “sub-Saharan 
Africa” to ensure that studies from the region in which Malawi is located were not 
missed.  This Chapter highlights gaps in the current available evidence base to illustrate 
the relevance of the thesis objectives outlined in chapter 5 and put into context the thesis 
findings presented in chapters 7, 8, 9 and key recommendations presented in chapter 
10.   
3.0 What is the current evidence base for Results-based financing? 
Witter et al note that the wide diversity of RBF design options, contexts in which 
they are applied, multiple objectives and range of possible effects–both intended and 
unintended-present a particular challenge identifying and summarising the best 




observation that most of the evidence comes from evaluation of individual RBF 
schemes in which the focus was primarily on the specific objective(s) of the scheme in 
question. Nonetheless, efforts to summarize RBF results have been attempted (Oxman 
and Fretheim 2009, Witter, Fretheim et al. 2012, Glassman, Duran et al. 2013, Gorter, 
Ir et al. 2013, Das, Gopalan et al. 2016, Turcotte-Tremblay, Spagnolo et al. 2016).  
Parallel to dimensions used to measure a health intervention performance previously 
outlined in section 2.1 and based on existing literature (Gorter, Ir et al. 2013, Das, 
Gopalan et al. 2016, Turcotte-Tremblay, Spagnolo et al. 2016) there are five mutually 
exclusive dimensions into which RBF effects can be categorized  Box 1.  The reported 
RBF effects are presented along these dimensions, separating findings from outside the 
SSA region from those in the SSA region. Two reasons justify this division. First, most 
RBF results from outside the SSA region are demand-side while those from the SSA 
are predominantly supply-side. Second, this demarcation highlights other salient 
features, such as dynamic health policy environments and generally weak healthcare 
systems, which are frequent in the SSA context (Turcotte-Tremblay, Spagnolo et al. 
2016).  
 
Box 1 : Five dimensions for presenting evidence for RBF effects, with example indicators.  
 
1)  Coverage with maternal and perinatal healthcare 
o Increase in provision of facility-based deliveries 
o Increase in access for facility-based deliveries 
2)  Quality of maternal and perinatal healthcare 
o Increase in adherence to clinical guidelines 
o Increase in content of maternal and perinatal care  
3) Equity in utilization of maternal and perinatal healthcare 
o Narrow gap in access for poor compared to least poor 
o Increased share of poor benefiting from maternal and perinatal care 
4)  Efficiency of results- based financing schemes  
o Cost per capita relative to funding options 
o Cost per death averted and or life year gained 
5)  Impact on maternal and perinatal health 
o Reduced maternal and perinatal morbidity 




Source: Author construction based on Gorter, Ir et al. 2013, Das, Gopalan et al. 2016, Turcotte-
Tremblay, Spagnolo et al. 2016 
3.1 Effects of RBF schemes on coverage with maternal and 
perinatal healthcare 
Two recent reviews relevant for the assessment of evidence for RBF schemes on 
selected maternal and perinatal health indicators were identified. The first focuses on 
supply-side PBF (Fretheim, Witter et al. 2012) while the second focuses on demand 
side schemes such as CCT and Vouchers, some of which were implemented with supply 
side elements e.g. incentives for community health workers (Glassman, Duran et al. 
2013). The majority of studies are on demand side schemes e.g. (Lim, Dandona et al. 
2010, Nguyen, Hatt et al. 2012, Bellows, Kyobutungi et al. 2013). 
Because of its pivotal role in maternal and perinatal health (Filippi, Ronsmans et 
al. 2006, Darmstadt, Yakoob et al. 2009), facility-based delivery is the most commonly 
evaluated indicator for coverage of pregnant women and the new-born with maternal 
and perinatal healthcare  (Fretheim, Witter et al. 2012, Bellows, Conlon et al. 2013). 
Although there are other relevant indicators that are also used to measure MNH 
coverage Table 2, the review is limited to using facility-based delivery as the proxy 
indicator of MNH service coverage. It is beyond the scope of this thesis to provide 
detailed evidence on all indicators of MNH coverage. Facility/ institutional based 
delivery denotes births that take place in a health facility.  
Table 2: Indicators of maternal and perinatal healthcare coverage according to stage of pregnancy. 
Antenatal period Delivery period Postnatal period 
o Antenatal attendances 
o First trimester 
attendance 
o Maternal vaccinations 
o HIV testing for mothers 
o Mothers initiated on 
ART 
o Diagnosis and treatment 
for sexually transmitted 
diseases e.g. Syphilis 
o ITN distribution 
o Facility delivery rate 
o Skilled birth attendance 
rate 
o Caesarean section rate 
o Administration of 
Nevirapine to HIV 
exposed new born 
o Complications referral rate 
o Treatment of 
complications 
o Posta natal care visits 
o Maternal check-ups 
o Neonatal check-ups 
o Modern family 
planning uptake 
o Infant vaccinations 
 
 
ART=Anti-retroviral therapy, ITN= Insecticide treated nets, HIV=Human Immunodefieciency Virus 




Given that researchers use different study designs and analytical approaches, 
there are variations in analytical rigour and the ways changes in facility-based delivery 
coverage are presented, which make comparisons between publications challenging. 
However, a reasonably consistent picture of positive effects of different RBF schemes 
on facility delivery coverage exists. In the following sections, specific RBF scheme 
names rather than RBF, the umbrella term, are used to focus on the evaluated RBF 
schemes.  
3.1.1 Evidence from outside sub-Saharan Africa 
Lim et al evaluated one of the world’s largest CCT program, India’s Janani 
Suraksha Yojana, employing three analytic approaches (exact matching with logistic 
regression, with versus without, and district level difference-in-differences) to estimate 
the effects of maternal receipt of CCT on several maternal and child health indicators 
including coverage for institutional delivery. All three analytical approaches 
consistently showed that CCT increased institutional-based deliveries (Lim, Dandona 
et al. 2010). In Nepal, Powell-Jackson et al used propensity score matching methods to 
assess another CCT program. They reported that women who had heard of the program 
before childbirth were more likely to deliver in a health facility (Powell-Jackson and 
Hanson 2012).  Similarly, positive results are found for voucher and health equity fund 
schemes. For example, Ir et al analysed both a voucher scheme and Health Equity funds 
in Cambodia (Ir, Horemans et al. 2010). They noted that facility-based deliveries 
increased sharply after the introduction of the voucher and health equity funds schemes. 
In Bangladeshi, both Ahmed et al  (Ahmed and Khan 2011) and Nguyen et al (Nguyen, 
Hatt et al. 2012) also reported that voucher program participants were more likely than 
non-participants to deliver babies in a health facility.  An exception to these results is a 
recent cluster randomized study of a PBF scheme in Afghanistan that failed to 
demonstrate any effect of the PBF scheme on facility births (Engineer, Dale et al. 2016).  
3.1.2 Evidence from sub-Saharan Africa 
With the exception of one of the earliest studies conducted in the democratic 
republic of Congo (DRC) which demonstrated more coverage of facility-based births 




in Uganda which failed to demonstrate positive impact of CCT on facility births (Kahn, 
Iraguha et al. 2015), results from SSA are consistent with the majority of findings from 
outside the region in that they are generally positive. For instance, in Kenya, Bellows 
et al found that women who benefited from a voucher scheme were more likely to 
deliver in a facility compared to the time before the scheme launch (Bellows, 
Kyobutungi et al. 2013). Similarly, another voucher study in Kenya by Obare et al also 
reported an increased likelihood for facility-based delivery in intervention areas 
compared to non- intervention areas (Obare, Warren et al. 2013).  
Arguably, the strongest evidence for impact of RBF schemes on facility-based 
delivery coverage in SSA comes from studies that have used more robust econometrics 
methods, specifically difference-in-differences approaches based on before-after 
studies with controls. A cluster randomized study by Basinga et al in Rwanda is one of 
the earliest (Basinga, Gertler et al. 2011). They reported an 8.1 percentage point increase 
in facility-based deliveries in PBF areas.  Priedman-Skiles reported similar results, 
again from Rwanda (Priedeman Skiles, Curtis et al. 2012).  In  Burundi, Bonfrer et al 
reported that compared to control  sites, PBF increased the likelihood of women 
delivering in an institution by 5 percentage points (Bonfrer, Soeters et al. 2013) while 
in Tanzania, Binyaruka et al have reported an 8.2  percentage point increase in facility-
based delivery for PBF relative to non-PBF areas (Binyaruka, Patouillard et al. 2015). 
In Uganda, Alfonso et al indicated that a voucher scheme increased the share of women 
delivering in an institution by 9.4 percentage points (Alfonso, Bishai et al. 2013). 
Figure 4 summarizes results of these RBF schemes effects related to facility-based 
births in SSA under different baseline settings. The observed percentage point increases 
range from 5 to 10 and appear to be higher when baseline facility-birth coverages are 






Figure 4: Plot of baseline facility-based births coverage (first Y axis) versus percentage point increase 
in facility deliveries following RBF implementation (second Y axis).  
Illustrating the relation between the share of facility-based deliveries attributable to RBF schemes (in 
percentage points) and baseline facility births for selected studies in sub Saharan Africa.  The dotted 
line is a fitted percentage points line, estimated by ordinary least squares approach. Note: Care should 
be taken in interpreting the figure as no attempt was made to control for other factors including the level 
of confidence for the point estimates.                  Source: Author calculations  
3.2 Effects of RBF schemes on quality of maternal and perinatal 
healthcare 
The multi-faceted nature of quality is reflected in the many variable indicators 
used to measure it.  They range from assessments of content of care i.e. antenatal 
services provided (Rahman M, Ubaidur R et al. 2009, Basinga, Gertler et al. 2011) ; 
fraction of health workers with appropriate training in a service of interest (Meuwissen, 
Gorter et al. 2006); the mean score for health workers knowledge in a particular clinical 
area (Meuwissen, Gorter et al. 2006); perceived improvements in quality of care for 
selected health services (Meuwissen, Gorter et al. 2006, Soeters, Peerenboom et al. 
2011) and structured observations of content of clinical care conducted using a checklist 
and summarized into composite quality score (Basinga, Gertler et al. 2011, Bonfrer, 
Soeters et al. 2014). Others have assessed quality in terms of quantity and stock-outs  of 
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Binyaruka and Borghi 2017, Brenner, Wilhelm et al. 2017). Mixed evidence of RBF 
effects on quality was found.  
3.2.1 Evidence from outside sub-Saharan Africa 
In Nicaragua, Meuwissen et al assessed satisfaction with care among voucher 
users compared with non-users (Meuwissen, Gorter et al. 2006). They reported high 
satisfaction with care among users, especially related to clinic reception and clarity of 
doctors' explanations. In a related study, the same authors assessed provider’s 
knowledge, practice and attitudes before and after a voucher scheme. They found a 
general improvement in health provider’s knowledge, attitude and practices after the 
voucher scheme (Meuwissen, Gorter et al. 2006). 
In Mexico, Barger et al measured quality in terms of received procedures that 
corresponded with clinical guidelines for history taking, diagnostics, physical 
examination and prevention. They indicated that births among women beneficiaries of 
a CCT program (Oportunidades) received more prenatal procedures compared with 
non-beneficiaries (Barber and Gertler 2009).  
3.2.2 Evidence from sub-Saharan Africa 
In Rwanda, Basinga et al assessed quality in terms of compliance with Rwandan 
prenatal care clinical practice guidelines (Basinga, Gertler et al. 2011). They reported 
an increase in prenatal quality among PBF recipients. In neighbouring Burundi, Bonfrer 
et al reported that overall quality scores for health care facilities improved during PBF 
intervention period, but noted that PBF had no effects on the quality of care as reported 
by mothers (Bonfrer, Soeters et al. 2014). The latter results are consistent with those 
reported by Binyaruka et al in Tanzania, who reported no effect of P4P on patient 
experience of care for targeted services, including facility births (Binyaruka, Patouillard 
et al. 2015).  
Finally, related to PBF impact on quantity and quality of equipment used for 
deliveries, Rudasingwa et al report that PBF improved quality of care in supported 
facilities in Burundi (Rudasingwa, Soeters et al. 2015). But recent more in-depth studies 
have shown mixed results. While Binyaruka et al found that PBF had no effect on 




et al in contrast reported that a PBF scheme  in Malawi had positive effect on availability 
of functional equipment (Brenner, Wilhelm et al. 2017).   
3.3 Effects of RBF schemes on equity of maternal and perinatal 
healthcare 
With respect to facility-based deliveries, equity is usually measured in terms of 
rates of facility-based deliveries across women’s social economic status or areas of 
residence. Somewhat mixed evidence on equity, especially from the SSA region, was 
found. 
3.3.1   Evidence from outside sub-Saharan Africa  
In Pakistan and Bangladesh, Agha  (Agha 2011)  and  Ahmed et al (Ahmed and 
Khan 2011) both report that poor voucher recipients were more likely to deliver in a 
health facility than the non-poor recipients, implying that voucher schemes had more 
effect in terms of increasing demand for facility delivery on the poor.   
3.3.2    Evidence from sub-Saharan Africa  
In Rwanda, Priedman-Skiles et al studied whether PBF reached the poorest of 
the population and  helped to close the gap in service use between the least poor and 
poorest women (Priedeman Skiles, Curtis et al. 2012). They found no evidence that PBF 
is pro-poor (and neither did they found it pro-rich). While Bonfrer et al found PBF pro-
rich results in Burundi (Bonfrer, Soeters et al. 2014), in contrast, Binyaruka et al found 
pro-poor results for facility-based delivery in Tanzania. In particular, they found an 
increase in institutional-based  deliveries among the middle tercile relative to the least 
poor tercile, and among the poorest tercile relative to the least poor tercile (Binyaruka, 
Patouillard et al. 2015). In view of these findings, Priedman-Skiles et al argue that  
supply side schemes e.g. PBF as a policy tool is not adequate, in and of itself, to 
overcome demand side barriers and reduce inequality in facility use (Priedeman-Skiles, 
Curtis et al. 2015). The consistently pro poor results based on demand side schemes 
such as CCTs (Ahmed, Creanga et al. 2010, Agha 2011) in part supports this argument.  
3.4 Efficiency of RBF schemes 
Cost information on RBF schemes including data on program start-up costs is 




(Liu, Hotchkiss et al. 2008, Borghi, Little et al. 2015, Turcotte-Tremblay, Spagnolo et 
al. 2016).  
3.4.1 Evidence from outside sub-Saharan Africa  
In Cambodia, Bhushan et al found that PBF increased the public cost per capita 
against the comparison mean, $2.93 vs $1.59, (Bhushan I, Keller S et al. 2002). But 
private out of pocket expenditure among PBF recipients reduced significantly so that 
total costs (from a societal perspective) reduced or remained constant. Because the PBF 
scheme brought about better results–in terms of financial risk protection-than 
conventional funding approaches, they argued this is suggestive evidence that PBF is 
more efficient. Similar results were found by Cercerone et al in Costa Rica (Cercerone, 
Briceno et al. 2005). Private per capita expenditures were 30% lower in clients attending 
contracted PBF clinics, but there were no demonstrable improvements/differences in 
health outcomes between contracted and un-contracted clinics. This implies that, at least 
from the patient perspective, the same outcomes were achieved at lower costs.  
3.4.2 Evidence from sub-Saharan Africa  
In DRC, Soeters et al reported that although per capita expenditure were lower in PBF 
than non-PBF areas ($2.4 vs $9.0), results were comparable and sometimes better in 
PBF areas, which they interpreted as indicative evidence for PBF efficiency (Soeters, 
Peerenboom et al. 2011).  
Only one CEA study in the SSA region based on a voucher scheme in Uganda 
was found (Alfonso, Bishai et al. 2013). Relative to status quo care, Alfonso et al 
reported an incremental cost-effective ratio of $20,756 and $302 per maternal death and 
per DALY averted, respectively. Since the $302 per DALY averted is lower that 
Uganda gross domestic product (GDP) per capita, they argued that the voucher scheme 
was cost-effective.  
Regarding specific costs related to a facility-based delivery, wide variations in 
costs are reported. While Alfonso and Mayora found low cost per delivery for a voucher 
scheme in Uganda of $20 and $24, respectively (Alfonso, Bishai et al. 2013, Mayora, 
Ekirapa-Kiracho et al. 2014), Borghi et al found much higher cost per additional 




to $261 for a national program (Borghi, Little et al. 2015). Care needs to be taken when 
making head to head comparison of unit costs across RBF schemes given differences 
in design and implementation. For instance, unlike voucher schemes, PBF schemes may 
require substantial infrastructural and equipment upgrades (Shepard, Zeng et al. 2015) 
which have implications for unit cost estimates. 
The relatively lower unit costs under scaled up national program settings as 
reported by Borghi et al indicates that the efficiency of PBF may depend on economies 
of scale (Borghi, Little et al. 2015), as previously suggested by Soeters et al (Soeters, 
Habineza et al. 2006). Thus these costs variations can also be explained in part by the 
scale of implementation and probably the costing methodology used (Mayora, Ekirapa-
Kiracho et al. 2014).  
3.5 Impact of RBF schemes on maternal and perinatal health 
outcomes 
The aim of RBF schemes as applied to MNH is to improve maternal and perinatal 
health outcomes. For these outcomes, evidence is scarce and largely points towards lack 
of evidence for RBF impact on health outcomes (Gopalan, Mutasa et al. 2014, Das, 
Gopalan et al. 2016).  
3.5.1   Evidence from outside sub-Saharan Africa  
Earlier studies on India’s Janani Suraksha Yojana CCT program by Lim et al 
found positive effects of CCT receipt on perinatal outcomes, and the program was 
estimated to reduce perinatal deaths by 4.1 per 1,000 births (Lim, Dandona et al. 2010). 
In contrast, a recent study found no effect of CCT on perinatal outcomes or maternal 
complications (Mohanan, Bauhoff et al. 2014).  Other recent  evaluations are consistent 
with these results, finding no improvement on neonatal mortality, even in districts with 
relatively high quality care (Powell-Jackson, Mazumdar et al. 2015). Similarly, in 
Cambodia, Van de Poel et al found no impact on neonatal mortality for a voucher 
scheme, despite demonstrable increase in institutional deliveries (Van de Poel, Flores 




3.5.2    Evidence from sub-Saharan Africa  
No study reporting impact of RBF on maternal mortality was found while only 
one study reporting on neonatal health outcomes was available from the SSA region. In 
Rwanda, Chari et al reported no RBF effect on neonatal mortality (Chari and Okeke 
2014).  
It is worth noting that the studies evaluating RBF schemes impact on health 
outcomes did not explicitly take quality of care into account. A recent study from 
Malawi evaluating the effects a ban of traditional birth attendants had on institutional-
based births has demonstrated that neonatal outcomes are better among births in better 
quality facilities compared with births in poor quality facilities (Godlonton and Okeke 
2016). Although not done within the context of an RBF, these findings are instructive, 
as they suggest the reported lack of RBF effects on health outcomes maybe explained 
in part by lack of quality of care in the evaluated health facilities.  
3.6 Gaps in RBF evidence base.  
Limited evidence for RBF schemes in all five thematic dimensions as illustrated 
in Box 1 was found. Additionally, the strength of this evidence appears low due to 
multiple constraints. Limitations of the evidence have been highlighted by others (Liu, 
Hotchkiss et al. 2008, Fretheim, Witter et al. 2012) so only key points are hereby 
summarized.  First, some of the studies were done while the local health policy 
environment was changing as well. For example, Rwanda introduced PBF within a 
system of community-based health insurance (Basinga, Gertler et al. 2011) while in 
Burundi user fees for facility deliveries and care for under-fives were removed at the 
same time it adopted the performance-based approach (Bonfrer, Soeters et al. 2014). 
These policy actions may have fostered the use of maternal and perinatal healthcare 
services by individuals and households, making it difficult to disentangle the effects of 
the performance-based payments. Second, given the usual lag between intervention and 
impact, most of the studies were evaluated within a time period that can be considered 
too short for the programs to have matured enough to show full effects let alone to 
observe longer-term trends (Glassman, Duran et al. 2013, Bonfrer, Soeters et al. 2014). 
Third, some studies e.g. (Lim, Dandona et al. 2010, Bellows, Kyobutungi et al. 2013) 




and technical input, which may have also contributed to the observed effects. Forth, 
especially relevant for the conflicting results from India, Mohanan et al point out study 
limitation to internal validity such as i) failure to adequately address self-selection of 
women into institutional delivery ii) inability to correct reporting of inaccuracies by 
hospitals and iii) inability to account for any increases in institutional deliveries over 
time that is unrelated to RBF (Mohanan, Bauhoff et al. 2014).  
3.7 Summary of RBF evidence.  
In summary, the evidence base for RBF is mixed.  Variations in RBF 
performance exist within and across the five performance dimensions, driven by 
context, scheme design, quality of implementation and analytical approaches. 
Nonetheless, the existing knowledge base appears suggestively positive in relation to 
intermediate and direct program effects (e.g. facility coverage and quality of care) 
highlighting the need for research related to distal and indirect population level health 
impacts (e.g. morbidity and mortality outcomes). Specifically, for the SSA region, less 
research on health outcomes and even lesser research on RBF cost-effectiveness exists. 
Lack of this information has important implications for both RBF related policy 
formulations and programming.  
CHAPTER 4:  Malawi  
This section situates the research within the Malawi context by providing a brief 
overview of the economic setting, the health system structure, the current maternal and 
perinatal health situation, and background to key maternal and new-born health policies, 
strategies and programs in the country.  
4.1 Economic background 
Malawi is a narrow and landlocked country that shares boundaries with Zambia 
in the west, Mozambique in the east, south and southwest, and Tanzania in the north 
(MoH 2011). It has an estimated population of about 17 million people, 52 % of which 
are females (NSO 2008). For administrative purposes, the country is divided into three 
regions. The southern region is home to 50% of the population and Blantyre, the largest 
commercial city in the country; the central region is home to 40% of the population and 




Mzuzu as its main commercial city. The three regions are further sub-divided into 28 
districts Figure 5.  
 
 
Figure 5: Top right -map of Africa showing the location of Malawi. Middle- map of Malawi showing 
the three administrative regions and their respective districts.  
Source: Maps of the World 
Malawi has a gross domestic product (GDP) of 4.2 billion US$ and a per capita 
income of US$ 482 (Trading Economics). Agriculture is the most important sector, 
accounting for 35 percent of the GDP. The country’s major exports are tobacco, tea and 
sugar. Combined, these produce account for approximately 85 percent of domestic 
exports (World Bank 2010). Most of the population (80%) especially in rural areas are 
engaged in small-scale subsistence farming.  
The World Bank classifies Malawi as a low income country based on per capita 
income level (World Bank). According to the 2012 integrated household survey (IHS), 
50.7 percent of the population are classified as poor; while 24.5% are considered ultra-
poor (National Statistics Office and Republic of Malawi 2012 ). IHS uses relative 
poverty lines to classify an individual. An individual is poor if her consumption is less 




per person per day plus the cost of basic non-food daily needs. An individuals whose 
consumption falls below the cost of the food bundle alone is  classified as ultra-poor 
(National Statistics Office and Republic of Malawi 2012 ).  
4.2. Level and distribution of general health status  
Over the past two decades, Malawi has made some improvements in overall 
population health including life expectancy and some key health indicators. For 
instance, following its reduction during the 1990s as a results of the HIV epidemic, life 
expectancy increased from 37 years in 2003 to 40 years in 2005 (Matchaya 2007); by 
2010, it was 49 years, higher that  it was in 1990 (DHS 2010), suggesting  significant 
offsetting of the HIV impact. This improvement is also reflected in other health 
indicators – such as under five mortality (64 per 1000 live births) and facility based 
deliveries (96%) (DHS 2016). Yet, several other health indicators are below targets, 
Box 2. Importantly, the country still experiences a high burden of disease. HIV/AIDS, 
respiratory tract infections, malaria, diarrhoea and ischemic heart disease are the leading 
causes of death (IHME 2015).  
4.3 Level and distribution of maternal and perinatal health status 
Malawi is one of few countries in the SSA region which managed to reduce child 
mortality rates in line with the formally Millennium Development Goals (MDGs) 4 
(child mortality) (Kanyuka, Ndawala et al. 2016) and the country has made some 
progress, though slow, in relation to MDG 5 (maternal mortality).  Even so, the current 
rates of both maternal and perinatal mortality remain relatively high. 
From 1990 to 2000, the maternal mortality ratio (MMR) in Malawi declined 
from 1,100 to 750 deaths per 100, 000 live births, a decrease of 32% (WHO, UNICEF 
et al. 2014). The major causes of maternal deaths were haemorrhage, sepsis, pregnancy 
induced hypertension, obstructed labour and abortions (Malata A 2010). Between 2005 
and 2010, the MMR further dropped from 570 to 510 per 100,000 live births (WHO, 
UNICEF et al. 2014). Estimates for the year 2015 put the MMR at 574 per 100,000 live 
births (DHS 2016). On the other hand, between 2000 and 2010, perinatal mortality rate 
(PMR) fluctuated from 41 per 1,000 births in 2000 to 34 per 1,000 births before rising 






Figure 6: Trends in maternal mortality (1990 to 2015)  and perinatal mortality (2000 to 2010).  
Source: Author calculations.  
 
 
Box  2: A summary of socio-demographic features and selected health indicators for Malawi.  
Population: 17,377,468a 
% Females of reproductive age: 25b 
GDP per capita:482c 
Health expenditure per capita:US$28d 
% Poor:  50.7e 
Life expectancy at birth: 
   For females:62f 
   For males:  58f 
Maternal mortality ratio: 574g 
Perinatal mortality rate:  40b 
Facility delivery rate: 96%g 
Total fertility: 4.4g 
Women with at least one antenatal clinic visit: 96%g 
Women with at least four antenatal clinic visits: 45%g 
HIV prevalence: 10.6b 
Number of doctors per 100,000 Population: 1.9i 
Number of nurses per 100,000 Population: 283i 
Sources: Malawi 2008 Population and housing census reporta, Malawi DHS 2010b, Trading Economics, 
2016c O'Hare and Curtis 2014d. Integrated Household Survey 2012e, Malawi MDG Endline Survey 
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4.4 Health system structure 
Malawi is a former British colony and as such, inherited or adopted a universal 
model of healthcare system, characterized by a large share of health facilities being 
public, large proportion of public health financing and central management. Despite 
ongoing efforts over the past decade towards decentralization, the health system in 
Malawi remains very centralized and vertically managed (Government of Malawi, 
2002).  
4.4.1 Health financing  
The Malawi general government health expenditure as share of general 
government expenditure in 2014 was 11.4 % (WHO 2014), less that the 15% target set 
by heads of African Union countries  in Abuja (African Union 2001).  Malawi’s health 
care financing relies on general tax revenue on personal income and company profits, 
trade taxes and grants from donors (Government of Malawi and Ministry of Health 
2011). 
The government's annual budget allocation to health and projected allocations 
are shown in Figure 7 for the years 2011 to 2016. Total health care expenditure has 
shrunk in absolute terms over the 5 years largely due to reduced government of Malawi 
contributions to the health budget. Donors contribute significantly to health financing 
and the level of their contributions have largely remained unchanged. Others have 
argued that this high dependence on external funding not only threatens long term 
sustainability of national health budgets but may also make health system financing 






Figure 7: Malawi Health care budget in million US$ (2010 US$) for years 2011 to 2016.  
 Data for financial years 2014/15 and 2015/16 are projections. Adapted from O’hare and Curtis, 2014. 
4.4.2 Per capita expenditures on health 
Healthcare spending has steadily increased from US$5.3 per capita in 2004/5, to 
US$16.3 per capita in 2008/09 and declined slightly to an estimated US$14.5 per capita 
in 2009/10 (Ministry of Health 2011). Per capital healthcare spending estimate in 
2012/13 was US$28. It’s worth noting that these per capita spending figures do not 
include private spending on health. In 2014, the estimated out-of-pocket payment as % 
of total health expenditure in the country was 12%, amongst the lowest in the region 
(Bayarsaikhan D and Musango L 2016).  
Pertaining to reproductive health (RH), estimates show that the expenditure rose 
from US$50.1 million in 2009/10 to US$74.3 million in 2010/2011, and then declined 
to US$63.6 million in 2011/12 (Ministry of Health 2014). On average, US$9.9 per 
annum was spent on RH over the same period on each woman of reproductive age 15–
49 years, (MoH 2014) 
4.4.3 General health services 
The health system is three tired (MoH 2011) and aims to provide an essential 
healthcare package (EHP)  targeting priority diseases free at point of use. Health centres 























individuals, are at the centre of EHP delivery, providing both preventive and curative 
healthcare for the general population.  They play a key role in providing communities 
with a broad spectrum of services such as behaviour change and health education (e.g. 
promotion of antenatal care and use of mosquito nets), vaccinations, growth monitoring 
and screening, and treatment of common infectious illnesses such as malaria and 
respiratory tract infections. Health centres and clinics refer patients for further 
management to district hospitals (secondary level). There is at least one public district 
hospital in each district catering for approximately 400,000 to 600,000 individuals. 
District hospitals are staffed and equipped to manage most patients with complications 
or severe diseases and offer comprehensive curative services including intensive 
inpatient care.  When appropriate, district hospitals refer cases for additional and 
specialized care to referral hospitals (tertiary level). One public referral hospital is in 
each of the regional main cities; Blantyre, Lilongwe and Mzuzu.  
Public health facilities provide the majority (60%) of health services in the 
country.  Private non-profit making Christian Health Association Mission (CHAM) 
hospitals and health centres, which charge subsidized user fees, provide about 37% of 
health services (CHAM 2016 ). The rest of healthcare is provided by private for-profit 
clinics, mainly in urban areas. 
4.4.4 Challenges facing general health services provision.  
The provision of quality health services in Malawi is facing challenges, such as 
shortage of drugs and equipment, long distance to facilities and poor attitudes of health 
workers.  Malawi also has a serious shortage of health workers. For example,  only 2 
doctors and 283 nurses are available for every 100,000 people (WHO 2014), Box 2. In 
addition, healthcare resources (staff and facilities) are not evenly distributed as they are 
more concentrated in urban areas, meaning that the shortfalls are even larger in rural 
areas (Abiiro, Mbera et al. 2014).  
4.4.5 Specific maternal and perinatal health services.  
Maternal and new-born care (MNC) in Malawi is provided as a package within 
the context of EHP.  The overall MNC package includes focused antenatal care, delivery 




country. MNH care is mostly free of charge at point of use both for public facilities and 
for CHAM facilities that have signed Service Level Agreements with the MoH. 
MNC is supposed to be provided by health facilities capable of providing 
emergency obstetric care (EmOC). Malawi subscribes to international guidelines (UN 
2009), thus EmOC facilities in the country are expected to provide a set of seven key 
interventions also known as “signal functions” for health facilities providing basic 
EmOC (BEmOC) while health facilities providing more sophisticated care through 
Comprehensive EmOC (CEmOC) are expected to provide an additional two more 
advanced key interventions.   
UN guidelines recommend at least 5 EmOC facilities, one of which should 
provide CEmOC services, for every  500,000 population (UN 2009).  Studies in Malawi 
have consistently shown that while there is adequate coverage for CEmOC facilities, 
there is a deficit of BEmOC facilities, underscoring the need to improve EmOC services 
in peripheral communities (MoH 2015).  Ideally, health centres providing BEmOC are 
expected to manage simple obstetric complications (such as removal of a retained 
placenta) and to only refer emergency cases requiring more comprehensive care (e.g. 
blood transfusions and surgical interventions) to respective district hospitals equipped 
to provide such CEmOC services.  
4.4.6 Challenges facing maternal and perinatal health service provision 
There are several concerns and challenges facing provision of maternal and 
perinatal care, which are like general health care limitations. Unique ones relate  to the 
lack of knowledge and skills among healthcare providers, resulting in failure to 
recognise obstetric complications and manage them appropriately (Grady, Ameh et al. 
2011), leading to conditions being referred that are otherwise anticipated to be managed 
at health centre level. Especially for rural health facilities, quality of care issues 
encompasses lack of access to emergency obstetric care,  inadequate transport systems 





4.5 Maternal and child health policy environment and programs in 
Malawi. 
Public health sector policies, alone or in conjunction with those from other 
sectors such as education, have huge potential for securing health of communities in a 
country (Don de Savigny and Taghreed Adam (Eds) 2009). The public health care act 
of 1948 and the constitution of the republic of Malawi mandates the MoH in the country 
to formulate health policies aimed at promoting the health of the nation through 
provision of oversight for implementations of both preventive and curative health 
services (GoM 1948). Within this legal framework, the MoH has over the years 
produced key policy and strategy documents, program and treatment guidelines 
including initiating specific reforms to facilitate maternal and child health promotion. 
The most important health policies addressing maternal and child health were 
enacted in the post independent era in the 70s.  The first to be launched was the maternal 
and child health program (MCH) in 1973 (Chirambo 1987). The aim of the program 
was to promote maternal and child health outcomes through increasing coverage of 
preventive services such as antenatal screening for mothers, provision of vaccinations 
and growth monitoring for children ≤ 5 years of age. To ensure adequate service 
delivery at primary level health facilities and access to these services in rural areas, the 
program was accompanied by initiatives to train lower cadre health workers and 
involvement of community health volunteers. This was followed by the launch of 
Expanded Program of Immunisation (EPI) in 1976 (Minetti, Kagoli et al. 2013). EPI 
aims to increase vaccination coverage for immunizable diseases and reduce mortality 
in children ≤ 5 years of age.  These two programs were successful in increasing service 
delivery in rural areas and increasing overall national service delivery coverage.  
The global economic crisis of the 80s reduced economic growth in developed 
countries (Fan, Duran et al. 2013). As a result, the amount of donor aid to poor countries 
was reduced. In response, structural adjustment programs were recommended in 
developing countries as a means to reduce government expenditures- including 
expenditures on healthcare (Loewenson 1993). To maximise health from dwindling 
resources, developing countries including Malawi formulated a minimum package of 




prioritized provision of selected affordable and cost-effective interventions at primary 
level for illnesses of public health importance (MoH 2002). It is worth noting that 
services related to maternal and child health constitutes an important component of the 
EHP.  
In 2005, a group of industrialized nations (G8) decided to provide debt relief to 
highly indebted countries like Malawi (Mutume 2005). To accelerate attainment of the 
MDGs 4 and 5, the Malawi MoH took advantage of the extra resources and invested 
them to improve social service delivery including health. The extra funding was  aligned 
to respond  to both high maternal mortality in the country  and to global and regional 
calls for each country to develop a country-specific road map, to accelerate reduction 
of maternal, new-born and child deaths (Republic of Malawi and Ministry of Health 
2005). Malawi prepared and launched the national road map strategic plan in 2005. The 
purpose of the road map is to ensure improved coordination of interventions and 
delivery of services for the MNCH subsector and to guide implementation across 
operational levels of the health system and standardize monitoring and evaluation.  
Other strategies with bearing on MNCH have since been rolled-out, the latest 
being the launch of Results based financing for MNH (RBF4MNH) in 2012 (Brenner, 
Muula et al. 2014). The Malawi RBF4MNH initiative is a response to findings of an 
EmOC needs assessment in the country which reported that most facilities meant to 
provide basic EmOC could not meet United Nations (UN) criteria, and that 70% of 
pregnant women with complications had unmet need for EmOC (Ameh, Msuya et al. 
2012).  
4.6 The Malawi RBF4MNH initiative   
 
The RBF4MNH initiative in Malawi is designed to improve service quality at MoH 
designated EmOC facilities by approaching both the supply and demand sides. From the supply 
side, PBF is provided to health providers in intervention or RBF4MNH supported health 
facilities (hence forth called RBF) based on achievements of pre-defined targets. The targets 
include such items as institutional deliveries and compliance to active management of third 
stage of labour. The PBF payments are made retrospectively approximately every quarter: 70% 




improving facility infrastructure and supplies.  Hospitals receive 60% for top-up and 40% for 
investments. From the demand side, the initiative uses CCTs to change health seeking 
behaviour of pregnant women residing in the catchment areas of RBF facilities to deliver at 
MoH designated EmOC facilities instead of at home. The CCTs, averaging US$ 10.50  per 
client (Brenner S and De Allegri M 2015) are therefore conditioned on deliveries in RBF 
supported facilities. The RBF implementation was preceded by a one-off investment in 
infrastructural upgrades and equipment supplies. This was to ensure that the providers/health 
facilities had the required capacity to provide quality MNH care (Brenner, De Allegri et al. 
2015) Table 3 provides a summary of key maternal and child health strategies and 
programs in Malawi.  
Table 3: A Summary of key maternal and child health strategies and programs in Malawi 
Year  Program/ Strategy  Purpose  
1973 Maternal and Child Health program Improve and expand MCH services  
1979 Expanded program of Immunization (EPI) Improve coverage of immunizations in children ≤ 5 
1980 National Malaria Control program 
(NMCP) 
Guide national malaria prevention and control 
1982  Family Planning (FP) adopted nationally Reduced fertility and promote MCH outcomes 
1993 First country to adopt SP for malaria 
treatment 
Reduce malaria related deaths and morbidity  
1995 National strategic plan for safe 
motherhood launched 
Promote reproductive health, promote MCH outcomes 
1996 Safe Motherhood Program initiated  Reduce maternal and neonatal mortality  
1999 National reproductive health strategy 
Integrated Management of Childhood 
illness (IMCI) enacted 
Promote reproductive health. Improve child survival by 
increasing access to common infections (malaria, 
respiratory tract infections and diarrhoea) 
2000 Child Lung Health Program Reduce respiratory morbidity and mortality  
2002 Service level agreements (SLA) with 
mission hospitals  
To address maternal and child services gaps and 
increase coverage.  
2003 National HIV policy launched Reduce HIV infections and mortality 
2004 Essential health care package  Provide minimum essential care at primary level 
2004 Post abortion care strategy  Reduce abortion related mortality and morbidity  
2005 National Road Map for Accelerating the 
reduction of maternal and neonatal 
mortality and morbidity  
Strategic guidance to key maternal and child health 
problems from policy to implementations 
2006 Child Health Days  To increase coverage of child survival interventions 
such as vaccinations  
2010 Option B+ for PMTCT To reduce mother to child transmission of HIV 
2012 Result based financing strategy for 
maternal and neonatal health 
Reduce maternal and neonatal mortality through 
Increase of quality institutional care.  
 




4.7 Summary  
The lack of evidence on RBF effectiveness in reducing maternal / perinatal 
mortality and on its efficiency as documented during the literature review (Chapter 3), 
combined with the challenges associated with providing quality MCH care in Malawi, 
as documented in this chapter, in combination logically set the grounds for the 
objectives for this PhD project as outline in the following Chapter.   
CHAPTER 5: Aims and objectives 
5.0 Aim 
The overall aim of the thesis is to contribute towards strengthening the economic 
evidence base, in Malawi and the rest of the sub-Saharan African region, related to 
results-based financing as a mechanism to strengthen healthcare systems and increase 
facility based-provision and utilization of priority and quality maternal and perinatal 
healthcare. 
5.1 Specific objectives 
The thesis has three specific objectives: 
1) To estimate from secondary data maternal and perinatal mortality risks for 
facility-based deliveries compared with home deliveries in sub-Saharan Africa; 
2) To estimate the effects that RBF has on household costs and time to seek facility 
care for women experiencing pregnancy related complications; 
3) To estimate the cost-effectiveness of obstetric care provided under RBF as 
compared to status quo obstetric care. 
Each objective was selected based on its suitability to investigate and provide 
information on each of the three thesis questions outlined in Chapter 1, section 1.3. 
Literature review and meta-analytic methods were used to provide estimates of maternal 
and perinatal mortality risks and to highlight gaps in epidemiological data. The results 
of the literature review, in particular the identified information gaps, informed the 
design of service use for pregnancy related complications and associated cost analyses. 
Finally, the combination of meta-analytic, service use and costing analyses allowed 
modeling of cost effectiveness of RBF that would not have been possible using a single 






Figure 8: Illustrates the relationship between the three thesis objectives.  
CHAPTER 6:  Methods  
This thesis draws on a mix of methodologies to answer the three thesis 
objectives. Correspondingly, section 6.1, section 6.2 and section 6.3 describe the 
methods used for studies I), II) and III). Finally, section 6.4 describes the process 
followed during the studies to ensure that study procedures conformed to ethical 
guidelines and standards. Summary descriptions of the study designs and methods used 
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Table 4: Overview of study designs, analytical approaches and data sources  
Study design Analytical approach and data sources  
Study I 




A structured and systematic search of databases, with primary focus on PubMed, 
using pre-agreed eligibility and exclusion criteria. Eligible studies were assessed 
for quality using a modified Newcastle-Ottawa scale for cohort studies. Extracted 
information was pooled using both fixed effects and random effects models in 
meta-analyses to estimate the risk of maternal and perinatal mortality by place of 
delivery in sub-Saharan Africa.  
Study II Cross-sectional surveys  
Primary household costs and time till service use data were collected at 
community level in four districts in Malawi. Data were collected at baseline in 
2013, midline in 2014 and endline in 2015. Using a before and after approach 
with controls, generalized linear models were used to estimate effects receipt of 
RBF (PBF+CCT) had on household costs and expected mean time to seek care 




This study used primary cost data collected from 4 randomly sampled health 
facilities in Malawi, project document reviews and household costs collected as 
part of study II. Effectiveness data (percentage change in service use) were 
obtained from RBF4MNH impact evaluations. Additional secondary information 
was obtained from review of published articles in sub-Saharan Africa. Adopting 
a societal perspective, costs   and health benefits were estimated over a one-year 
time horizon, using a decision tree model programmed in TreeAge software 
©2016. Incremental cost-effective ratios were estimated in terms of deaths 
averted and life years gained.  
6.1 Study I 
Pursuant to specific object 1 (To estimate from secondary data maternal and 
perinatal mortality risks for facility-based deliveries compared with home deliveries in 
sub-Saharan Africa): A systematic search of peer reviewed population-based studies 
involving pregnant women and reporting on risk of maternal and or perinatal mortality 
at the individual level by place of delivery in the sub-Saharan region was conducted. 
6.1.1 Search strategy 
The search was conducted between January and August 2013 and followed 
guidelines for meta-analysis of observational studies in Epidemiology (MOOSE) and 
preferred reporting items for systematic reviews and meta-analysis (PRISMA) (Stroup, 
Berlin et al. 2000). Medical and social science databases and journal libraries searched 
included, but were not limited to, PubMed, EBSCO Host, Web of Science, 
ScienceDirect, Wiley, Cochran library and Google Scholar. The following key words 
were used in various combinations “Maternal mortality”, “Maternal deaths”, “Perinatal 
mortality”, “Perinatal deaths”, risk, “Place of birth/delivery”, study, Africa and “sub-




following definitions applicable to the SSA region were used. Maternal deaths were 
defined as all direct and indirect obstetric deaths during pregnancy, delivery, and the 
first 42 days after birth (Abouzahr 2011). Perinatal deaths were defined as pregnancy 
losses occurring after seven completed months of gestation, or deaths within the first 
seven days of delivery of a live born child (early neonatal deaths) weighing 1000 grams 
or more (ICD-10). Place of delivery was denoted facility-based (births or delivery in a 
formal health facility whether or not attended by a skilled medical attendant) or home 
(births or delivery outside of a formal health facility whether or not attended by a skilled 
traditional birth attendant). 
6.1.2 Study selection 
A multi-stage procedure was used to select studies of interest.  In the first stage, 
titles and abstracts of publications retrieved during database searches were screened. In 
the second stage, full articles of abstracts and titles that appeared concordant with the 
inclusion and exclusion criteria were retrieved. In the third stage, full articles that did 
not meet the study inclusion criteria were excluded.  
6.1.3 Inclusion criteria 
o Cohort and or demographic surveillance studies. 
o Studies reporting on pregnancy outcomes from 7 complete months until 7 days 
after birth.  
o Studies reporting on maternal deaths as soon as pregnancy was identified until 
42 days after birth.  
o Studies written in the English language. 
o Studies published between 1990 and 2013. 
o Studies conducted in the sub-Saharan African region. 
6.1.4 Exclusion criteria 
o Study design other than cohort or demographic surveillance e.g. surveys.  
o Studies which under reported outcomes i.e. with <25% assignment of outcomes 




o Studies where reported data could not completely fill a 2 × 2 table illustrating 
maternal/perinatal outcomes (live or dead) by place of delivery. 
o Studies reporting only on risk of an exposure (e.g. HIV infection or severe 
anemia in pregnancy) or an intervention (e.g. Prevention of mother to child 
transmission of HIV) on perinatal or maternal mortality. 
6.1.5 Study quality  
Each retrieved study was subjected to a quality review using a modified 
Newcastle-Ottawa scale for cohort studies (Wells, Shea et al.). The key information 
related to study quality assessed included representativeness of the study population, 
population characteristics such as gestation age at enrolment and duration of pregnancy 
follow up, information about study design (population-based cohort vs. demographic 
and health surveillance), ascertainment of exposure, proportion of home deliveries, and 
use of standard definitions for main outcome measures and denominators (e.g. births, 
live births). In addition, information that may have affected estimates of the primary 
outcomes including frequency of data collection, proportion of refusals, loss to follow 
up and sample sizes was also extracted. 
6.1.6 Data extraction 
From each study, general study information (e.g. year of study publication and 
names of authors) and the primary health outcomes for the study (e.g. maternal and 
perinatal mortality ratio by place of delivery) was obtained. As the outcomes of interest 
are ratios, information on relevant numerators and denominators to enable independent 
calculations of these ratios was also extracted. This information was used to estimate 
denominators by simple proportion in instances where an appropriate denominator (e.g. 
number of live births at home) was not provided while the numerator and corresponding 
appropriate ratio was given.  
6.1.7 Study outcomes  
Study 1 had two main outcomes. 
o Odds ratio of maternal mortality for facility births relative to home births  




The odds of maternal mortality among facility births was defined as the number of 
maternal deaths among facility-based births divided by the number women who did not 
experience deaths/ lived (among facility births). Odds of maternal deaths among home 
births were similarly defined.  The odds ratio (OR) of maternal mortality for facility 
births relative to home births was calculated as odds of maternal mortality among 
facility births divided  by odds of maternal mortality among home births (Bland and 
Altman 2000). The same definitions and calculations were used for estimating the OR 
for the perinatal mortality for home births relative to facility births.  
6.1.8 Statistical analysis 
Quality scores for each study were categorized in two: high if more than 60% of 
the quality items were reported and low otherwise. The crude OR by place of delivery 
in each study was estimated. The individual study crude ORs were then used to calculate 
the weighted average of the OR across the studies using meta-analytic procedures 
(Kirkwood and Sterne 2003). The OR can be combined using two approaches. Fixed 
effects models weight studies according to the amount of information they contain while  
random-effects models incorporate an estimate of between-study variation in the 
weighting (Harris, Bradburn et al. 2008, Haidich 2010). Study heterogeneity was 
assessed using I2 statistic, which measures the percentage of variation in OR attributable 
to heterogeneity between studies. As recommended (Higgins, Thompson et al. 2003), 
the fixed effects model was used when I2 was low < 50%, otherwise the random-effects 
model was used to calculate individual study OR,  corresponding 95% confidence 
intervals (95% CI) and to pool the results across the studies. 
6.1.9 Estimates of effects 
The potential effect of place of delivery on maternal and perinatal mortality was 
estimated in terms of attributable risk percentage reduction, defined as the portion of 
the incidence of an outcome in the exposed that is due to the exposure:  
[(𝐼 − 𝐼 )/𝐼 ] ∗ 100 
Where Iexp and Iun are incidences in the exposed and unexposed groups, respectively 
(Daly and Geoffrey 2007). In this analysis, this represented the incidence of mortality 




deliveries) were eliminated. A Poisson method was used to calculate mortality ratios 
and their associated 95% CIs as this method approximates distribution of these ratios 
better (Bouvier-Colle, Ouedraogo et al. 2001). STATA version 12.0 (Stata Corp, 
College Station, Texas) was used for the analysis.  
6.2 Study II 
Pursuant to objective 2 (To estimate the effects that RBF has on household costs 
and time to seek facility care for women experiencing pregnancy related 
complications): This study used quantitative methods to evaluate impact of RBF on 
healthcare use by women experiencing pregnancy and delivery related complications, 
and the associated household economic costs. The utilization and economic cost data 
were gathered through household surveys. Surveys are considered best approaches for 
collecting standardized responses on individuals’ behaviours across a large sample of 
subjects (Patton, 1990). Importantly and pertinent to this study, when survey data are 
collected at more than one point in time, they allow for assessing direction of observed 
associations  using analytical statistical techniques (Kelley, Clark et al. 2003).  
The sections below describe the intervention (RBF4MNH), study sites, 
populations and data collection methods that were used to evaluate the Malawi 
RBF4MNH initiative. Because study II was nested within the RBF4MNH impact 
evaluation, the methods used for both studies were essentially similar.  
6.2.1 The intervention 
The RBF intervention, designed to work with incentives to promote quality and 
encourage services use, is as described previously in section 4.6.  
6.2.2 The comparator 
The comparator or status quo MNH care is as detailed previously in section 4.4.5.  
In contrast to the RBF facilities, non-RBF facilities (comparators) did not receive 




6.2.3 Study sites 
The RBF study was conducted in four out 
of the 28 districts in Malawi. The districts were 
purposefully selected so that they were relatively 
representative of the rest of the districts in the 
country in terms of maternal/childhood illness 
patterns and administrative arrangements. The 
selected districts were Mchinji, Dedza and 
Ntcheu in the central region and Balaka in the 
southern region, Figure 10. These districts have 
an approximate population of 2 million, about 
12% of the national population. Women of 
reproductive age constitute 25% (500,000) of the 
study districts population.  
The four districts have a total of 33 health 
facilities designated by the Malawi Ministry of 
health as capable of providing BEmOC or 
CEmOC services. The RBF initiative focused on 
women of reproductive age living within the 
catchment areas of these 33 health facilities.  
6.2.4 Study design  
In 2013, the MoH selected 17 health facilities out of the 33 EmOC health 
facilities (4 district hospitals/CEmOCs and 13 BEmOCs) to be recipients of the 
RBF4MNH initiative. One year later, the initiative was expanded to include a total of 
28 health facilities (5 CEmOC and 23 BEmOCs) with the remaining health facilities 
serving as controls. Selection of facilities by MoH was non-random.  Facility catchment 
population size, geographical EmOC coverage, facility’s performance of emergency 
obstetric care signal functions and functionality of referral structures were the criteria 
used for selection.  
The supply-side component was rolled out at the selected CEmOC and BEmOC 
facilities soon after the official launch of the program in April 2013. However, due to 
Figure 9: Map of Malawi showing the four 
study districts.  




implementation challenges, the demand-side component was rolled out progressively 
across the RBF4MNH facilities and only became fully functional one year later (2014) 
as illustrated in Figure 10 
6.2.5 Enumeration areas and household selections 
A three-stage cluster sampling procedure was used to select study areas. In the 
first stage, catchment areas of the 33 health facilities capable of providing EmOC 
services were designated as clusters. Depending on size, each cluster contained 11-45 
Enumeration areas (EAs). EAs are administrative data collection units, demarcated by 
the National Statistics office (National Statistical Office 2010) and  contain about 500 
households with a mean of 1,500 people (National Statistical Office 2008). In the 
second stage, EAs were randomly sampled within each cluster: two EAs for health 
centres (BEmOCs) and four for district hospital catchment areas (CEmOCs), to allow 
for larger populations and rural-urban differences in the district hospital areas. In the 
third stage, at least 26 eligible women were randomly selected from each EA.  
To identify the women, fieldworkers started by finding a central point in the EA, 
spin a bottle and then walked in the direction the bottle pointed while visiting all 
households between the central point and the EA border. Household were included if 
they met eligibility criteria, detailed in section 6.2.12 below. If not, fieldworkers moved 
on to the next household.  Once the EA border was reached, fieldworkers then moved 
about 100 meters either side of the border before starting moving towards the central 
point again. This was done to ensure that selected households did not cluster around the 
EA central point but were spread throughout the EA so that the sampled women were 
representative of the EA. It was emphasized to the fieldworkers during training to 
adhere to this procedure. The fieldworkers worked in pairs in the selected EA, visiting 
alternate houses and consulting with one another or their supervisors in case of 
uncertainty. 
6.2.7 Data collection 
Data was collected through three repeated cross-sectional household surveys. 
The first survey was conducted at baseline (April-May 2013), the second was conducted 




During each survey, questions were asked spanning 12 months period preceding the 
survey as shown in Figure 11. 
 
 
6.2.8 Survey interviewers 
Trained interviewers collected data from the eligible women using a structured 
questionnaire, programmed digitally using Open Data Kit (ODK) software and 
administered using Samsung Galaxy-Tab-2.0 tablet computers. The use of tablet 
computers was motivated by the known advantages of electronic data capture compared 
to paper based questionnaires (Fanning and McAuley 2014). For example, use of tablet 
computers precludes the need for manual data entry, which in turn eliminates data entry 






Figure 10:  Provides information on incentives and data collection periods for evaluation of the 
Malawi RBF4MHH initiative 
The vertical arrow indicates when supply-side incentives to health workers were applied to 
Intervention facilities. The intervention facilities in addition received gradual demand-side 
incentives for women from 2014. Blue horizontal arrow represents intervention facilities. White 
horizontal arrow represents control facilities. Horizontal axis shows the before and after periods and 
timing of data collection.  Back pointing arrows indicate the 12 months recall period data was 
Supply side incentives in 
Intervention facilities start April 
2013 
Demand side incentives were rolled out progressively 





errors and shortens the time between data collection and data availability for systematic 
exploration/inspections and analysis. In addition, checks and skips were programmed 
into the questionnaire, preventing fieldworkers from accidentally skipping questions 
and alerting fieldworkers if invalid entries were made. This improved both data quantity 
and quality. Loops ensured that only appropriate questions were asked depending on 
respondent’s unique situation. For example, if a woman did not experience any 
complication during previous pregnancy, then complications related questions were 
automatically not asked.  
It’s worth noting that this electronic approach has disadvantages too, particularly 
when used in resource poor settings. Sufficient time is needed to train field workers, so 
they can build competence in using tablet computers, competent information 
technology (IT) support is required for programming and troubleshooting, reliable 
internet and regular power are needed to send the information from tablets to a central 
server according to laid down schedules.  While hiring of enumerators with experience 
in use of tablet computers and regular IT support from both Universities of Malawi and 
Heidelberg, Germany, allowed for a less challenging enumerator training, in the field, 
the following challenges were experienced. Poor internet coverage prevented regular 
uploading of data to the central server, risking loss of data if a tablet was stolen or 
damaged. Most evenings, supervisors had to search for areas with strong network 
signals, incurring extra fuel costs and distracting from working on other tasks such as 
getting timely/ adequate feedback from the fieldworkers or preparing for next day 
activities.  Frequent blackouts always threaten tablet power. This threat was minimized 
by having spare tablets (additional survey costs) and using car battery power to charge 
the tablets.  
6.2.9 Pre-survey training and piloting 
About 18 enumerators took part in gathering each wave of household survey 
data. The enumerators were mainly non-health workers. Given that some of the 
household data was intended to be used in study II, I was very involved in the training 
of these enumerators.  Their training, which included piloting of the questionnaire, was 
carried out over an average five-days period before each of the surveys. The training 




A paper version of the questionnaire with English and Chichewa translations was 
used to train the enumerators during the initial phase (first two days) of the training.  
This was done to ensure the enumerators had good understanding of the questions, how 
they were related and to verify that the Chichewa versions were true reflections of their 
English counterparts. Following this, three days were committed to the use of tablet 
computers with only the Chichewa version of the questionnaire. The fieldworkers 
practiced using the questionnaire as a group and then in pairs; interviewing each other, 
taking turns to act as interviewer and respondent.  
Important and challenging parts of questionnaire development relate to ensuring 
that all important questions are included, are asked appropriately, that the flow of the 
questions is logical, and that checks and skips are working properly or as intended. I 
therefore took part in systematically testing the questionnaires individually and in 
groups during training, taking notes of important observations that required changes to 
the questionnaire or program.  After this class work, the questionnaires/ tablets were 
piloted in rural villages in Blantyre on volunteer women who had ever given birth. After 
piloting, more modifications were made to the questionnaires to improve question 
readability and clarity. These changes mainly related to modifications to the 
questionnaire wording to make them more generic and context appropriate and 
simplifications of questions or adding lead in questions in cases where there were 
evidence respondents had difficulties understanding questions as initially phrased. All 
interviewers were Malawians and fluently spoke Chichewa, the common local 
language.  The questionnaire (Appendix 1: Questionnaire) was administered in 
Chichewa.  
6.2.10 Data Collection 
 Information collected included details on the women’s social demographic 
features e.g. age, education and marital status, reported complications and hospital 
admissions due to complications related to the most recent pregnancy (Appendix 1: 
Questionnaire). The information on self-reported complications was collected in the 
form of lay person descriptions of a combination of symptoms and signs suggestive of 
common obstetric complications (Nahar, Banu et al. 2011). This information was 




facility discharge slips, where possible. For each reported complication, information 
about relevant out-of-pocket expenditures on medical costs (consultations, drugs and 
laboratory fees) transport costs, food and accommodation were recorded. Time use for 
seeking and obtaining care for both patient and their guardians was also recorded. All 
women reporting a complication were asked if they sought care. If the response was 
yes, the women were then asked to report how quickly after symptoms onset they had 
decided to seek care, and how many days elapsed before they presented to a facility 
once decision to seek care was made. 
6.2.11 Data management 
At the end of each field day, electronic data collection forms were checked for 
completeness and accuracy of recordings before being sent to a central saver. During 
data collection, the database (in the central saver) was regularly reviewed for 
completeness. Information in the database was crosschecked with information from 
field reports regarding number of interviews, EA locations and dates the interviews 
were conducted. Any disparities, duplicates or missing records were corrected by 
referencing the appropriate tablet computers. During the study, access to electronic 
records was restricted only to study staff or enumerators using passwords.  
6.2.12 Inclusion and exclusion criteria 
As mentioned above, section 6.2, study II was a sub-study of the household 
surveys, conducted as part of   RBF4MNH impact evaluation. As such, data used in the 
analyses for study II are from a truncated sample of the respondents for household 
surveys.  
Respondents data were used in study II if  
o Respondents were aged ≥ 15 years old 
o Respondents had completed a pregnancy (either through miscarriage, abortion, 
stillbirth or delivery of a live baby) during the 12 months before day of survey 
o Respondents had experienced a pregnancy or delivery related complication at 
any point during their pregnancy  
o Respondents provided fully informed voluntary consent and the relevant 




Respondents data were excluded if 
o Respondents were <15 years old 
6.2.13 Study main outcomes  
Study II had two main outcomes 
o Total costs and  
o Time to seek care.  
Total costs: Total costs were defined as the sum of both direct costs (e.g. medical 
and transport fees) and productivity losses associated with each reported complication. 
Costs of time taken to seek care and actually spent at health facilities were estimated 
using the human capital approach (Jo 2014). Lost patient and informal guardian’s time 
in days for each reported complication were quantified and added up. Given the high 
level of self- or informal employment in the sample (>80%) and the lack of job specific 
mean wage information for those in formal employment, minimum wages were used to 
value lost productivity for both the formally and informally employed. Productivity 
losses (opportunity cost) were estimated as the product of the time lost and daily 
minimum wage pertaining to the survey year. Reported minimum wages per day in 
Malawi Kwacha (MK) were 317, 551, 687 for years 2013, 2014 and 2015 respectively 
(Malawi Labour Market Profile 2014). To compare the costs reported over the years, 
the annual Consumer Price Index (CPI) increases from 2013 to 2014, 2014 to 2015 and 
2014 to 2015 respectively was used to adjust the 2013 (baseline) and 2014 (midline) 
costs to 2015 (endline) values (1US$=550MK).  Hereafter, total household costs are 
simply referred to as costs, unless stated otherwise.  
Time to seek care: To estimate time taken till service use, women were 
prompted to recall when key symptom(s) for reported complication started. Time to 
seek care was defined as duration in days a woman with a reported complication took 
to present for care at a health facility after symptoms onset. Hereafter, time taken to 
seek care is simply referred to as time to care. 
6.2.14 Study Independent variables 
The main exposure was receipt of RBF4MNH, composed of PBF and CCT, for 




of the effect, independent variables identified as important determinants of care seeking 
(Gabrysch and Campbell 2009) and that  have local context and cultural relevance 
within the framework of understanding obstetric complications care seeking (Kambala, 
Morse et al. 2011, Combs Thorsen, Sundby et al. 2012) were included. The variables 
Table 5 include age, parity, education, socio-economic status (SES), area of residence, 
facility type and distance to facility. In addition, in view of the gradual roll out of CCT 
as previously explained section 6.2.4, three more variables were included. The first 
indicated if women were registered to receive CCT. The second related to those who 
sought care and indicated whether they were treated as in-patients (a proxy for disease 
severity). The third indicated the days spent in facility for women treated as in-patients. 
These three variables were included on the assumption that they would have bearing on 
costs. Following standard approaches, a wealth index based on household assets 
ownership was generated using principal component analysis  (Vyas and 
Kumaranayake 2006). The wealth index was used to rank the women into three SES 
terciles. 
Table 5: Independent variables and their coding 
Independent variable Definition, measurement and coding 
Age Continuous variable, measured in years 
Parity Number of term deliveries, categorized as 0 if < 2 term deliveries and 1 if ≥ 2 deliveries 
Married Marital status, categorized as 0 if woman not married and 1 if woman married 
Head Household Household head status, categorized as 0 if woman did not head household and 1 if woman 
headed household 
Educated Primary education attainment, equivalent to 8 years of schooling, categorized as 0 if woman 
had no primary school leaving certificate and 1if woman had primary school leaving 
certificate or above 
Residence Place of residence, coded as 1 if woman stayed in an urban area and 0 otherwise. 
Distance Continuous variable measured in kilometres to the nearest formal health facility 
Facility  Type of health facility, coded as 1 if a facility provided CEmOC and 0 if BEmOC. 
Registered Denotes enrolment to receive demand side incentives, coded 1 if woman enrolled and 0 
otherwise 
In-patient Coded as 1 if woman with self-reported complication was admitted for in-patient care and 0 
otherwise 
Days Continuous variable, measure as number of nights spent in facility 
Social economic status Coded as 0 if poor, 1 if middle and 2 if least poor 
 
 
6.2.15 Data analysis 
To compare and describe social-demographic characteristics of the women with 
a self-reported complication in the RBF and non-RBF groups, I used summary statistics 




square tests were used to assess differences in means and proportions, respectively, 
between the two groups. 
I first explored the data using ordinary least squares regression. Standard 
diagnostics showed that the main outcomes (household costs and time )  were  positively 
skewed and heteroskedastic Figure 11 making it problematic to use parametric analytic 
approaches (Mihaylova, Briggs et al. 2011). To estimate populations means, E(y|x), 
while considering the non-normal distribution of health care data, I therefore applied 
generalized linear models (GLMs). GLMs allow for making direct inference about 
expected population means without recourse to complex transformations or re-
transformations (Barber and Thompson 2004).  Total costs had trivial amounts of zeros 
(< 3%). Therefore a two part model, an approach often used in modeling cost data, was 
deemed  likely to have little effect on the overall predicted mean costs (Blough and 
Ramsey 2000). Thus, the cost analysis was limited into a single part prediction model.  
  
Figure 11: Regression diagnostics for the ordinary least squares on household costs.  
Plot of residuals versus fitted values illustrating non-constant variance of residual as costs increase, 
































GLMs require explicit specification of  the distribution (F) of the dependent 
variable and  the link function (g) describing how independent variables  are 
functionally related to the dependent variable (Blough and Ramsey 2000). A modified 
Parks test was used to select appropriate distribution and link functions for the study 
outcomes (Manning and Norton 2013). Through this test, it was found that a log link 
with Gamma and Poisson families respectively provided best fits for the costs and time 
data. The empirical GLMs took the form: 
𝑔(𝜇 ) = 𝛽 + 𝛽 𝑌𝑒𝑎𝑟 + 𝛽 𝑅𝐵𝐹 +  𝛽 𝑅𝐵𝐹 ∗ 𝑌𝑒𝑎𝑟 + 𝛽 𝑋 , 𝑦  ~𝐹      
Where 𝜇  denotes the study outcome of interest (costs/time) for every unit (pregnant 
woman seeking care for a reported complication), Yeari is a categorical variable 
indicating the time point taking value 0 at baseline, 1 at midline and 2 at endline, RBFi, 
is an indicator variable coded 1 if the unit is in the RBF group, 0 if in the non-RBF 
group, Xi is a vector of independent factors known to influence the dependent variables 
as outlined above. The estimable quantities of interest are thus: β0 a common constant 
for all observations, β1 effect of time on each unit, β3 the effect of treatment (and the 
main target of inference) and β4 representing a vector of coefficients for X Table 5. 
Because the decision to admit women with reported complications for in-patient care 
was based on clinical assessments, women admitted for care were considered a distinct 
subgroup. Therefore, two separate models for each of the primary study outcomes were 
ran: the first model included all women with a self-reported complication who sought 
care (full model), while the second was restricted to the women who were admitted 
(restricted model). As the models have a log link, the exponential of coefficients should 
be interpreted as the ratio of arithmetic means (Barber and Thompson 2004). The 
analysis generated robust standard errors and used the cluster command to allow for 
clustering of women at health facility levels. StataIC/14 (Stata-corp LP, Texas, USA) 
was used for the analysis. 
 6.3 Study III 
Pursuant to objective 3 (To estimate the cost-effectiveness of RBF compared with 
status quo obstetric care): This study evaluated the cost-effectiveness of RBF compared 




6.3.1 The intervention and comparator 
The intervention is as described in section 4.6. The comparator is as described in 
section 4.4.5.  
6.3.2 The decision model 
A decision tree model was used to calculate the expected health effects and 
expected costs of the RBF initiative from a societal perspective. The choice for using a 
decision tree was programmatic, influenced by data availability. Reflecting the 
financing options Malawi decision makers face, the decision model included two arms: 
RBF and non-RBF. Policy makers decide which facilities should receive RBF while 
mothers’ face different probabilities, within each arm, of delivering in an RBF health 
facility, non-RBF facility or at home. In the model, place of delivery probabilities are 
based on primary trial data. Mothers who delivered in RBF facilities benefited from the 
intervention (PBF + CCT) while those who delivered in non-RBF facilities did not.    
The model included information on population coverage with facility-based 
delivery (FD), the incidence of maternal complications, cause-specific maternal case 
fatality rates (CFRs), stillbirth and early neonatal mortality risks, time to seek care for 
complications and improvements in quality of obstetric care. The cost information 
included care seeking and associated treatments costs, including RBF costs for the 
intervention arm. The costs are presented in 2013 USD, which is the year the RBF 
program started.  
For each arm, the model tracked maternal and perinatal outcomes from 28 weeks 
gestation until 7 days after delivery. This cut-off is consistent with the definition of 
perinatal outcomes in developing settings (Lawn, Cousens et al. 2005, Froen, 
Cacciatore et al. 2011). Importantly, it focuses on capturing maternal deaths during the 
third trimester and the first week after birth, when the majority of deaths occur (Vogel, 
Souza et al. 2014). By comparing with the status quo, the model estimated incremental 
deaths averted and years of life gained (YLG) from perinatal and maternal mortality 
averted by the intervention as well as the additional (incremental) costs incurred by the 
RBF initiative. 
Figures 12 and 13 show the schema of the decision model. The full model was 





Figure 12: Pathways of maternal events, demonstrating maternal status after delivery.  
 
A is linked to perinatal outcomes for live mothers. B is linked to perinatal outcomes 
for dead mothers as shown in Figure 13. RBF-Results based financing. EmOC-
Emergency obstetric care. 
 
 
Figure 13: Pathways of perinatal events demonstrating conditional relationships between perinatal 
outcomes and maternal status after a delivery event.  
6.3.3 RBF effects on service use, quality and subsequent mortality 
reductions 
At population level, maternal/perinatal survival depends on coverage of pregnant 
women with facility-based delivery services of high quality, also known as effective 
coverage. The impact evaluation of the RBF in Malawi demonstrated significant 




RBF and non-RBF facilities: RBF significantly increased effective coverage in facilities 
by 10.5%-points (95%CI: 8.9−12.1%-points, p=<0.01) (Brenner, Wilhelm et al. 2017). 
In addition, receipt of RBF was associated with significantly reduced mean time to seek 
care for women experiencing complications (Study II), which may translate into better 
survival (Chinkhumba, De Allegri et al. 2017).  
Similar efforts to improve the quality of obstetric care were associated with 25 
to 30% reductions in CFRs and 19 to 20% reductions in stillbirth rates in Zambia and 
Uganda (CDC 2014). Assuming same effects in Malawi, the mean figures of 27.5% and 
19.5% reductions in CFRs and stillbirth rates, respectively, were adopted to estimate 
CFR and stillbirth rate reductions in RBF supported facility deliveries. Consistent with 
the Zambia and Uganda studies, it was assumed that RBF had no significant effect on 
early neonatal mortality. The mean estimates were used as baseline scenario and varied 
± 20% in sensitivity analysis Table 6. 
6.3.4 Epidemiological data 
Estimates of other key epidemiological parameters were obtained from the 
published literature as outlined below.  
6.3.4.1 Perinatal mortality  
Because some maternal complications can negatively affect perinatal outcomes, 
perinatal survival is linked to maternal survival (Saleem, McClure et al. 2014, Vogel, 
Souza et al. 2014). After a delivery event, the model therefore considered perinatal 
outcomes based on mothers’ status, i.e. whether the mother was alive or dead. The status 
of the new-born (stillbirth, early neonatal death, alive) was then assigned conditional 
on the status of their mothers Figure 13. Therefore, perinatal deaths were calculated by 
combining the risk of stillbirth and early neonatal mortality with information about the 
status (live or dead) of the mother after delivery.  
The estimates for stillbirth and early neonatal mortality rates are 28.4/1,000 
births and 19.3/1,000 live births, respectively, among a population-based cohort of 
mothers that survive births. For mothers that die soon after births, the estimated stillbirth 
and neonatal mortality rates are  318.8/1,000 births and at 89.9/1,000 live births, 




incidental maternal deaths are not linked to maternal complications, it was assumed that 
they are the same as for normal deliveries. These rates were transformed into 
corresponding probabilities following recommended approaches  (Fleurence and 
Hollenbeak 2007) Table 6. 
6.3.4.2 Adjusting perinatal risks by place of delivery   
Individual studies in SSA report mixed results on risk of perinatal mortality by 
place of delivery; some find that the risk is lower for facility-based deliveries 
(Walraven, Mkanje et al. 1995, McDermott, Steketee et al. 1996, Nankabirwa, 
Tumwine et al. 2011) while others report lower risk for non-facility based deliveries 
(Matendo, Engmann et al. 2011, Schmiegelow, Minja et al. 2012). Perinatal risk 
adjustment was based on a meta-analysis (Study I) that pooled results from population-
based cohort studies in SSA (Chinkhumba, De Allegri et al. 2014). The study reported 
a relative risk of 1.25 for perinatal death among home based births compared to facility-
based births. 
6.3.4.3 Incidence of maternal complications 
Information on incidence of maternal complications and respective case fatality 
rates is needed to calculate maternal deaths. To track maternal complications in the 
model, each delivery was defined as normal (not associated with a maternal 
complication) or complicated (associated with a maternal complication). Mothers 
experiencing maternal complications could experience a direct obstetric complication, 
such as haemorrhage, sepsis, obstruction and eclampsia or other/ indirect causes. Each 
complication could lead to a maternal death or recovery. The model allowed for the fact 
that mothers experiencing normal deliveries may die from incidental causes. There is 
wide variations in reported incidences of maternal complications even though countries 
by principle adhere to the same version of the International Classification of Diseases 
(World Health Organization 1992). A World Health Organization multi-country survey 
estimate of 7.3% maternal complications  prevalence associated with facility-based 
deliveries in developing countries was adopted (Souza, Gulmezoglu et al. 2013). Given 
the survey methodology rigor and inclusion of countries from SSA region, this is 
probably the most representative estimate, thus it was used as the baseline scenario. For 




lower, based on the fact that majority of women with complications normally self-select 
themselves into care (McClure, Goldenburg et al. 2007). 
There is lack of reliable data on case-specific incidences for sepsis, haemorrhage, 
eclampsia and obstruction (Leigh, Mwale et al. 2008, Kaye, Kakaire et al. 2011). 
However, data on relative frequencies of these conditions among women with 
complications exist. In Malawi rural facilities, sepsis, haemorrhage, eclampsia and 
obstruction have been showed to account for 32%, 32%, 20% and 11% respectively of 
obstetric complications, with other direct/indirect causes  accounting for the remaining 
5% (MoH 2000). Cause-specific incidences were thus estimated indirectly, by 
multiplying the relative frequency of each condition with the overall incidence of 
maternal complications.  
6.3.4.4 Maternal case fatality rates   
Regarding maternal case fatality rates (CFRs), wide variations exist in data for 
the SSA region. A review of recent estimates (year 2000 onwards)(Kaye, Kakaire et al. 
2011) reported that facility based CRFs range from 3.6-18.0% for sepsis (Prual, 
Bouvier-Colle et al. 2000, Kaye, Mirembe et al. 2003); 2.8 to 12.3% for haemorrhage 
(Prual, Bouvier-Colle et al. 2000, Oladapo, Sule-Odu et al. 2005); 3.4-18.0% for 
eclampsia (Prual, Bouvier-Colle et al. 2000, Kaye, Mirembe et al. 2003) and 2.0-12.7% 
for obstruction (De Bernis, Dumont et al. 2000, Kaye, Mirembe et al. 2003). For each 
CFR, the mean estimates were used as baseline scenario while the whole ranges were 
tested in sensitivity analyses to reflect this diversity of CFRs across SSA settings. As 
no corresponding data exists for women experiencing indirect complications and among 
home births, the mean CFR (0.09%) was adopted to identify deaths due to 
complications from other/indirect causes and during home births Table 6. For home 
births, this rate is likely to be on the lower side but may be justified in light of reports 
that  sometimes, the quality of care provided by the formal sector providers may not be 
much better than that provided by informal providers (Godlonton and Okeke 2016).  
6.3.4.5 Maternal mortality risks 
Though rare, a woman can have co-morbidities or experience more than one 
complication, raising the problem of competing mortality risks (Pintilie M 2006). The 




assumption that the risk of each maternal complication is independent from the risk of 
other complications. 
Mortality risk for incidental causes was thus approximated by subtracting 
annualized life time  risk for maternal death (1 in 34) for women of reproductive age,15 
to 49 years (WB 2015) from annualized all-cause mortality risk (0.0242) for women 
aged 25-29 years  (World Health Organization). 
6.3.4.6 Estimation of years of life gained.  
Malawi life expectancies at birth and at the mean age of women of reproductive age were used to 
calculate YLG (World Health Organization) for each perinatal and maternal death averted, respectively. 
Future YLG were discounted at 3%  in the baseline scenario (Shepard, Zeng et al. 2015), while the 
influence of no discounting of future health was explored in sensitivity  analysis.  Details of parameters 
used in the model and their sources are shown in Table 6 
 
 
Table 6: List of parameters used in Results based financing compared to non-Results based financing 






  *PSA probabilistic sensitivity analysis 
 
 Baseline  
aPSA  
Parameter  estimates distributions Sources  
Life years gained (discounted)    
Maternal years 25.02 ± 20%  (World Health Organization) 





Stillbirth if mother is alive   0.028 ± 20% Beta (Saleem, McClure et al. 2014) 
Stillbirth if mother is dead 0.273 ± 20%  (Saleem, McClure et al. 2014) 
Early neonatal death if mother is alive 0.019 ± 20%  (Saleem, McClure et al. 2014) 
Early neonatal death if mother is dead 0.086 ± 20%  (Saleem, McClure et al. 2014) 
Maternal death from incidental causes 0.004 ± 20%  (World Health Organization , WB 2015) 




Facility births 7.3 ± 20%  (Souza, Gulmezoglu et al. 2013) 
Home births  3.6 ± 20%  Assumption 




Sepsis 10.8 (3,6-18,0)  (Prual, Bouvier-Colle et al. 2000, Kanya, Obare et al. 2014) 
Haemorrhage 7.6 (2,8-12,3)  (Prual, Bouvier-Colle et al. 2000, Oladapo, Sule-Odu et al. 2005) 
Obstruction 7.4 (2.0-12,7)  (De Bernis, Dumont et al. 2000, Kanya, Obare et al. 2014) 
Eclampsia 10.7 (3,4-18,0)  (Prual, Bouvier-Colle et al. 2000, Kanya, Obare et al. 2014) 
Other/ complicated home births 9.1 ± 20%  Assumption 




Sepsis 32 ± 20%  (MoH 2000) 
Haemorrhage 32 ± 20%  (MoH 2000) 
Obstruction  11 ± 20%  (MoH 2000) 
Eclampsia  20 ± 20%  (MoH 2000) 
Others  5 ± 20%  (MoH 2000) 




RBF births 89.2± 20% Beta (Brenner, Wilhelm et al. 2017) 
RBF Effective coverage  77± 20% Beta (Brenner, Wilhelm et al. 2017) 
Non-RBF births 82.7± 20% Beta (Brenner, Wilhelm et al. 2017) 
Non-RBF Effective coverage  69.5± 20% Beta (Brenner, Wilhelm et al. 2017) 
RBF complication care seeking 78 ± 20% 
 
(Chinkhumba, De Allegri et al. 2017) 
Non-RBF complication care seeking 75 ± 20%  (Chinkhumba, De Allegri et al. 2017) 
Quality effects in RBF facilities (%)    
Reduction in maternal CFRs 27.5 ± 20% Beta (CDC 2014) 
Reduction in stillbirth rate 19.5 ± 20%  (CDC 2014) 
Reduction in early neonatal death rate 0  (CDC 2014) 
Relative risks    
Stillbirth, RBF vs Non-RBF facility 0.829 ± 20% Log Normal (CDC 2014, Saleem, McClure et al. 2014) 
Perinatal death, Home vs facility births 1.258 ± 20% Log Normal (Chinkhumba, De Allegri et al. 2014) 
Patient costs ($)    
Normal birth RBF facility 5 ± 20%  (Brenner S and De Allegri M 2015) 
Normal birth, Non-RBF facility 5 ± 20%  (Brenner S and De Allegri M 2015) 
Complicated birth Non-RBF facility 13.68 ± 20%  (Chinkhumba, De Allegri et al. 2017) 
Complicated birth, RBF facility 15.15 ± 20%  (Chinkhumba, De Allegri et al. 2017) 




6.3.5 Cost data  
Health systems and RBF program costs were collected from four health centres. 
Two districts were randomly selected and within each district, an intervention and a 
comparison health centre were also randomly selected. Data were retrospectively collected 
twice, spanning fiscal years 2013/14 and 2014/15, in June-July of 2014 and 2015 
respectively.  Given some differences in actual timing of RBF implementation between 
intervention health centres, the periods of data collection were not identical.  
The World Bank RBF toolkit was used to guide cost data collection (Shepard, Zeng 
et al. 2015). Costs were defined as variable costs (those that change with service volume) 
or fixed costs (those that do not change with service volume). For variable costs, an 
ingredient approach was used to estimate unit costs (Drummond, O'Brien et al. 1997, page 
67). At the health facilities, quantities of resources used for maternal and new-born care 
were identified and recorded. Pharmacy and inventory records were used to quantify drugs 
and other supplies. Unit prices were obtained from Malawi Central Medical Stores (CMS) 
catalogue or local retailers as appropriate (MoH 2013). Information on utilities and 
building maintenance were either collected at the health facilities or respective district 
offices, depending on where complete records were available. RBF data including on 
incentives, training, information and communication (IEC) materials, equipment supplies, 
and supervision were collected from both RBF desk officers at the health facility and/or 
the main office at the MoH reproductive health unit. The consumer price index was used 
to convert prices into 2013 constant prices while future costs were discounted at 3% 
(Shepard, Zeng et al. 2015).  
For fixed costs (building and equipment) information on useful life years and 
replacements costs was obtained from MoH Planning and Policy Directorate and from 
national health accounts (MoH 2014). Fixed costs were annualized and discounted at 3% 
rate. A top-down approach was used to allocate joint or shared costs using allocation 
proxies (Drummond, O'Brien et al. 1997, page 64) . The proportion of maternity unit area 




unit. The share of maternity unit clients among all visits was used to apportion health 
worker salaries. An implicit assumption is that the resource requirements of the maternity 
unit are equal to the average resource requirement of all facility activities. 
Information on number of deliveries staffing levels and cadres were taken from 
facility registers and other office documents e.g. human resource records. Costs related to 
administrative support from the district offices were not collected, on the assumption that 
they would not substantially differ between health centres. RBF personnel costs, office 
rentals and other overhead costs from the central office were captured by inflating all RBF 
costs by 38.8% so that overall RBF administrative costs would account for  28%, a figure 
reported as share of administrative costs for a pay for performance program in Tanzania  
(Borghi, Little et al. 2015). Household costs, including direct and indirect costs, associated 
with care seeking were based on earlier analyses (Study II). Local currency values were 
converted to US$ equivalents using 2013 midyear exchange rate (US$1=MK 330). 
6.3.6 Outcome measures 
Study III had two related outcomes: deaths averted and LYG. Thus, to assess which 
arm (RBF vs non-RBF) provided good value for money, incremental cost-effectiveness 
ratios (ICERs) were calculated in terms of cost per death averted and cost per LYG. 
6.3.7 Sensitivity analyses and parameter uncertainty 
The impact of each model parameter on ICERs was first explored through one-way 
sensitivity analyses. The mean of each parameter was varied over appropriate ranges, or in 
the absence of empirical estimates they were varied ± 20%, Table 6. The ten parameters 
that influenced the ICERs most were further assessed through probabilistic sensitivity 
analysis, after assigning them appropriate distributions. Gamma distributions were 
specified for costs, normal distribution for LYG, logNormal distributions for relative risks 
and Beta distribution for probabilities (Gray, Clarke et al. 2011, page 261). Bounds for the 
parameters were derived using methods of moments (Gray, Clarke et al. 2011, page 263). 
Parametric bootstrapping based on 5,000 iterations was conducted to propagate parameter 




plot and acceptability curves. At any given value of willingness to pay, acceptability curves 
show the probability of an intervention being cost-effective relative to the comparator.  
6.3.8 Model validation 
The model was validated by comparing estimated baseline perinatal mortality rates 
with estimates from the published literature (internal validity) and by inspecting that all 
parameters influenced the model according to expectations (face validity). 
6.4. Ethical approvals 
The overall RBF4MNH impact evaluation was approved by the Ethics committee 
at University Heidelberg, protocol number S-256/2012. In addition, except for Study I 
where secondary data were used, ethical approval was sought for Studies II and III from 
University of Malawi, College of Medicine Research and Ethics Committee (COMREC) 
protocol number P.02/13/1353. Finally, verbal permission to conduct the studies was also 
sought from district and village authorities. 
6.4.1 Informed consent 
For study II, fully informed voluntary written consent was obtained from all mothers 
in the local language before administration of the household questionnaire. (Appendix 2: 
Consent form). The information provided related to the study objectives, procedures, 
potential risks and benefits. The voluntary nature of the enrolment and the right to refuse 
or withdraw at any time was emphasized. 
The women were encouraged and given ample time to ask questions. Only after this 
process was completed were the women asked for written consent. In cases where the 
women were not able to read or write, the information was explained in the presence of a 
literate guardian not connected to the survey. Consent was then provided in the form of 
thump print.  
Two copies of the signed or thumb printed consent forms were made. One was given 
to the participant and the other was kept in lockable cabinets by the study manager at the 




For study III, only verbal permission was sought from MoH managers given that 
secondary cost data was used, extracted from accounts records and inventories, and did 
not contain personal identifiers.  
6.4.2 Ethical implications 
The ethical implications of the studies mainly related to interviews of mothers 
(Study II). Is it fair to ask for an interview while mothers had other important chores to do 
like taking care of their children or preparing their crop fields? Would participating in an 
interview negatively affect their other work? Are their harms in asking mothers to recall 
previous painful experiences such as losing a child during child births?  Careful 
considerations were given for these risks. Important steps taken to minimize these risks 
included training interviewers to be aware of these risks and allowing the women to stop 
interviews any time they felt uncomfortable. Women were also allowed to suspend 
interviews while attending to urgent household chores such nursing their children.   
CHAPTER 7:  What are the benefits of institutional deliveries 
when compared to home deliveries in sub-Saharan Africa?  
This chapter draws on findings from study I described in section 6.1. It explores the 
evidence in support of institutional based-deliveries in terms of maternal and perinatal 
mortality risks risk reduction. Challenges in estimating benefits of institutional deliveries 
are discussed.  
7.1 Systematic search results 
A total of 1,247 study citations were identified. Of these, 615 studies were discarded 
after appraising their titles as they contained irrelevant information. Abstracts for the 
remaining 632 studies were then screened, leading to the exclusion of 617 further studies. 
Excluded were studies that were not population based or did not report outcomes by place 
of delivery (n=594), assessed risk of an exposure or focused on impact evaluation of an 
intervention (n=19) or were duplicate publications (n=4). Thus, only 15 studies were 
retrieved in full, out of which 6 studies were further removed.  Five (5) prospective cohorts 




completely fill a 2 X 2 table illustrating outcomes (death/alive) by pace of delivery (Aisien 
AO, Lawson JO et al. 2000, Teija Kulmala, Merimaaria Vaahtera et al. 2000, Chalumeau 
M, Salanave B et al. 2000 , T. O. Lawoyin, M. O. Onadeko et al. 2010, Paul Welaga, Cheryl 
A. Moyer et al. 2013) while  1 study (Cyril Engmann, Paul Walega et al. 2012) did not 



























23 Additional articles identified 
through other sources e.g. 
conference proceedings 
 
1224 Articles identified through 
electronic database search e.g. 
PubMed  
 
1247 Article titles screened  
in total 
615 Articles excluded 
as titles contain irrelevant 
information 
632 Abstracts down 
loaded and screened 
 
617 Abstracts excluded 
594 are not population-
based studies 
19 evaluated other 
exposure or intervention 
4 are duplicate studies 
 
15 Full-text articles 
down loaded and 
assessed for eligibility 
6 Full-text articles further 
excluded 
5 do not have complete 
information to fill 2 X 2 
Table 
1 does not have adequate 
information on place of 
delivery 
9 Articles are included in meta-
analysis 
6 report on perinatal mortality 





 Figure 14: Illustrates how studies were identified, screened and finally selected for inclusion in the meta-
analysis of maternal and perinatal mortality in sub-Saharan Africa. 
Thus a total of 9 studies that met the inclusion criteria were obtained for the analysis: 
six (6) studies (Walraven, Mkanje et al. 1995, J. McDermott, V R. Steketee et al. 1996, 
Diallo AH, Meda N et al. 2010, Matendo, Engmann et al. 2011, Nankabirwa, Tumwine et 
al. 2011, Schmiegelow, Minja et al. 2012) reported on perinatal mortality, and the other 
three (3)  studies (De Bernis, Dumont et al. 2000, Bouvier-Colle, Ouedraogo et al. 2001, 
Høj L, da Silva D et al. 2002) reported on maternal mortality. All were population based 
prospective cohort studies.  
7.2 Quality of selected studies 
Table 7 shows that the mean study quality scores (Wells, Shea et al.) for the selected 
studies were 10 out of 15 possible points. The most common limitations identified were 
the lack of randomization in group allocation and the lack of independent blind assessment 
of study outcomes. The nine (9) retained studies contained information on 36,772 
pregnancy episodes in total. Of these 9,362 (25.5%) had information on the perinatal 
outcome alone. Further details on the characteristics of the studies included in the meta-





































































































































































































































































































































































































































































































































































































































































































































































    
 








































































































































































































































































































































































































































































































































































































































































































































7.3 The odds of perinatal mortality for home relative to facility births 
The odds of perinatal mortality by place of delivery was calculated to estimate the 
protective effect of place of delivery. A fixed effects model showed that the pooled crude 
odds of perinatal mortality was significantly higher for home compared to facility delivery 
(OR 1.21, 95%CI: 1.02-1.46) Figure 15. Due to a high between-study heterogeneity 
I2=73.7, the pooled effect was also estimated with a random effects model (DerSimonian 
R and Laird N 1986). The estimate from the more conservative random effects model gave 




Figure 15: Pooled analysis of perinatal mortality by place of delivery in sub-Saharan Africa. 
 



































Home reduces risk of PMR  Home increases risk of PMR 




The results of the individual studies were mixed. While two studies were  in favour 
of home delivery (Matendo, Engmann et al. 2011, Schmiegelow, Minja et al. 2012), one 
was  neutral (Diallo AH, Meda N et al. 2010) and the remaining three were  in favour of 
facility-based delivery (Walraven, Mkanje et al. 1995, J. McDermott, V R. Steketee et al. 
1996, Nankabirwa, Tumwine et al. 2011).  
Next, the actual perinatal mortality ratio (PMR) by place of delivery was estimated. 
Table 9 shows that the overall weighted PMR was 63 (95% CI:54-73) per 1000 births.  The 
PMR was 70 (95% CI: 57-86) and 56 (95% CI: 44-69) per 1000 births for home and 
facility-based deliveries, respectively. The attributable risk percentage reduction was 21% 
(95% CI:-6,40).  
  
 Table 9: Weighted perinatal and maternal mortality ratios by place of delivery in sub-Saharan Africa. 
Outcomes/ place of 
birth 
Dead            Alive Mortality ratio   
(95%CI)* 
Attributable Risk % 
(95%CI)* 
Perinatal mortality                                 Deaths/1000  
Home deliveries   95             1,258 70 (57-86) 21 (-6,40) 
Facility deliveries   82 1,387 56 (44-69)  
Total 177 2,645 63 (54-73)  
     
Maternal mortality   Deaths/ 100,000  
Home deliveries 38 6,302 599 (424-823) N/A 
Facility deliveries 35 3,668 945 (658-1315)  
Total     73 9,970 726 (570-913)  
 
7.4 The odds of maternal mortality for facility relative to home births 
Figure 16 shows that the estimated pooled crude odds ratio for maternal mortality 
at facility compared to home settings was 2.29 (95% CI: 1.58-3.31). There was no variation 
in OR attributable to heterogeneity, I-squared = 0%. The increased odds for maternal 
mortality at facility were consistently high across all the three individual maternal studies 





Figure 16: Pooled analysis of maternal mortality by place of delivery in sub-Saharan Africa. 
The overall weighted maternal mortality ratio (MMR) was 726 (95% CI: 570-913) deaths 
per 100, 000 live births. The MMR was 599 (95% CI: 424-823) and 945 (95% CI: 658-
1315) per 100,000 live births for home and facility deliveries, respectively Table 9. The 
high maternal mortality at facilities relative to home birth precluded estimation of 
attributable risk percentage reductions.  
7.5 Discussion 
7.5.1 Study strengths  
The strengths of study 1 are related to the deliberate decision to include studies with 
a homogenous design, that used standard definitions for study outcomes (perinatal and 
maternal mortality ratios) and that largely collected data prospectively and at regular 
intervals thereby minimizing recall bias and increasing validity of the outcome measures. 
This is in contrasts with common approaches used to  estimate perinatal and maternal  
mortality in  African countries which are based on complex statistical modeling techniques 
I-V Overall  (I-squared = 0.0%, p = 0.556)
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(Stanton C, Lawn JE et al. 2006) or  derived from nationally representative demographic 
and health surveys that use sisterhood approach methods (Lawn, Cousens et al. 2005). It 
has been reported that poor quality data, recall bias and selective under reporting tend to 
affect such estimates (Otia SO and Odimegwu C 2011).  
7.5.2 Study limitations  
Nonetheless, Study 1 suffers from some limitations. Because population-based 
cohort studies are costly, only a few have been conducted in the SSA region. Thus, despite 
the high quality of individual eligible studies, the pooled analysis is based on a limited 
number of studies. Also, subtle operational variations appeared in how the exposures were 
defined among the studies. For example, while home delivery in some settings meant 
delivery by non-trained traditional birth attendants (TBAs) (Walraven, Mkanje et al. 1995) 
in other settings it denoted delivery by  trained  TBAs (Matendo, Engmann et al. 2011). 
Despite the uniform study design used, such conceptual differences can lead to clinical 
variations and  heterogeneity (Haidich 2010). 
Differences in geographical, temporal, health systems and individual patient risk 
profiles can also affect maternal and perinatal outcomes (Scott and Ronsmans 2009) and 
thus confound interpretation of health outcomes by place of delivery. It is known for 
instance that rural areas tend to have worse perinatal and maternal health outcomes than 
urban areas (Ronsmans C and Graham WJ 2006). Within the SSA region, important 
variations  in the risk of mortality exist between sub-regions (Moyer CA, Dako-Gyeke P 
et al. 2013 ). At an individual level, age, parity and existence of other co-morbidities such 
as hypertension  can influence both maternal and perinatal outcomes (Høj L, da Silva D et 
al. 2002, Schmiegelow, Minja et al. 2012).  The implication is that these factors need to be 
controlled for before making statements about the relative effectiveness of one place of 
delivery compared to another (Lohela TJ, Campbell OMR et al. 2012). Although this was 
recognized, inadequate number of studies and particularly the lack of patient level 
information from the available studies precluded the possibility of such adjustments 




7.5.3 Perinatal mortality 
The study found evidence for increased chance of perinatal losses following home 
compared to facility-based deliveries at an individual level. However, opposite conclusions 
can statistically be reached, significant versus non-significant results, depending on 
whether fixed model or random effect model assumptions are made.  In a scenario where 
findings are statistically significant with the latter but not with the former model, it has 
been suggested the results should be viewed with caution (DerSimonian R and Laird N 
1986, Amit X. Garg, Dan Hackam et al. 2008).  
The overall weighted perinatal mortality ratio in SSA was estimated to be 63 (95% 
CI: 54-73) deaths per 1000 births. This figure compares well with current WHO estimates 
of PMR (56 per 1000 births) in the region (WHO 2007). The results imply that at best, an 
expected 14 perinatal deaths could be averted per 1000 births if women delivered at facility 
instead of home. This would represent a 21% (95% CI:-6,40) reduction in perinatal 
mortality risk for the home delivery group. To put this into perspective, it’s worth noting 
that in 2012, 36.8 million births were estimated to have taken place in SSA of which 18.0 
million (49%) were home deliveries (Singh S, Darroch JE et al. 2013). It can be argued 
that a 21% reduction in perinatal mortality risk might produce important public health 
improvements-in view of the high number of home deliveries in the SSA region- if a 
significant portion of the women who currently give birth at home could instead be 
motivated to deliver in health facilities.   
Regional practice and policy is needed to further put these results into context. The 
current practice in the region  encourages active or self-referral of pregnant women, 
especially those with high risk factors (e.g. twin pregnancy, pregnancy induced 
hypertension) to deliver at health facilities through health worker trainings and WHO 
policy (WHO 2005), This practice is reflected in some of the studies included in the 
analysis where special arrangements for facility  referral of at risk pregnancies were made 
(Walraven, Mkanje et al. 1995, Schmiegelow, Minja et al. 2012). This practice introduces 
selection bias making the facility and home delivery groups different with respect to 




study results might represent an underestimation of PMR in the home delivery group and 
an overestimation for facility deliveries. The observation that perinatal mortality is on 
average high in the home delivery group, despite its relative low risk profile, should thus 
be of concern to policy makers, program implementers and health care providers in SSA. 
7.5.5 Maternal mortality 
Pregnant mothers delivering in facilities have a significantly higher risk of 
experiencing a maternal death than women delivering at home. Possible reasons that may 
account for this surprising result are as follows. First, in settings where access to facility-
based delivery is low (<40%), women seeking care at facilities tend to  be complicated 
cases with higher risk of mortality (McClure, Goldenburg et al. 2007, Lohela TJ, Campbell 
OMR et al. 2012). Given the high risk selection, high maternal deaths would be expected  
as already reported in the literature (Ronsmans C, Chowdhury ME et al. 2010). Only one 
out of the three studies reporting on maternal mortality had a low  facility delivery  rate 
(Bouvier-Colle, Ouedraogo et al. 2001). However, precluding this study from the analysis 
did not significantly change the results, suggesting that in this study, low facility delivery 
rate alone does not appear to explain the relatively high risk of mortality observed for 
facility-based deliveries.  
Second, and related to the risk selection, the study by Høj et al shows a progressive 
increase in risk of maternal mortality from health centre to hospital compared to home: 
(OR 1.49,95% CI: 0.73-2.76) and (OR 2.72, 95% CI:1.64-4.38), respectively (Høj L, da 
Silva D et al. 2002). This suggests the existence of a differential in terms of the complexity 
of case mix by level of care. Bouvier-Colle and others argue that such a differential  can 
be interpreted as an indication that referral for facility-based delivery is actually working 
with secondary or tertiary referral facilities treating women with more complex conditions 
(Bouvier-Colle, Ouedraogo et al. 2001), although probably the timeliness of  care is not 
optimal to make a difference (Scott and Ronsmans 2009).  
Thirdly, it’s worth noting that facility-based delivery as a strategy to reduce 




to an enabling environment including availability of health workers with midwifery 
training, diagnostic tools, appropriate drug supplies and access to blood bank for effective 
care. In this regard, high risk of maternal mortality at facility may therefore reflect lack of 
requisite capacity for facilities to offer quality care to high-risk women (Blum LS, Sharmin 
T et al. 2006). There is empirical evidence supporting the premise that poor quality of care 
at health facilities is likely to explain a significant portion of the observed high risk of 
facility-based maternal deaths. A large study in the region has shown that most maternal 
deaths occurring at facilities are among women who receive substandard care (Bouvier-
Colle, Ouedraogo et al. 2001) while another has reported that not all facilities-based 
deliveries are attended by health workers with midwifery training due to unfilled vacancies 
and staff absenteeism (Mueller DH, Lungu D et al. 2011 ). Fourthly, the possibility that 
mothers might be harmed at facilities due for example to poor infection control or other 
human errors cannot be ruled out (Lohela TJ, Campbell OMR et al. 2012), although hard 
evidence is lacking.    
7.6 Conclusions 
Maternal deaths are relatively rare events posing challenges when estimating a 
maternal mortality ratio (Graham WJ, Filippi VGA et al. 1996 ). The observed high risk of 
maternal death at facilities makes it problematic to use this outcome measure to assess the 
potential impact of interventions that promote facility-based deliveries. Approaches that 
assess impact of interventions aimed at increasing facility-based deliveries in relation to 
reductions in morbidity, not just mortality, would be more appropriate.  Studies of maternal 
illness such as severe maternal complications, which occur in far greater numbers than 
maternal deaths, may instead allow for robust quantification and evaluation of  
interventions that promote facility-based deliveries  and have been suggested as 
alternatives to assessment of maternal mortality (Adeoye, Onayade et al. 2013).  
Put together, our results appear to suggest that as a strategy to reduce maternal and 
perinatal mortality, facility-based delivery is more likely to reduce perinatal than maternal 




facilities  emphasis the need for  quality improvement efforts to precede  activities aimed 
at increasing demand for facility-based deliveries in the SSA region (Maine D and 
Rosenfield A 1999). 
Evaluating the impact of facility-based delivery strategy on maternal and perinatal 
mortality using population-based studies is complicated by selection bias in favour of 
women that deliver at facilities and poor control of confounders. Studies that pool data at 
an individual level may allow for better control of confounding/risk modifying factors and 
provide better estimates of relative safety of places of delivery in the region. Future studies 
should focus on assessing the relative contribution of poor quality and delayed care seeking 
on facility based maternal and perinatal deaths to better prioritize resources and align 
interventions efforts. 
CHAPTER 8:  What are the effects of RBF on time to seek 
care for pregnancy related complications and household 
costs associated with such care seeking?  
This chapter draws on findings from study II described in section 6.2. The chapter 
describes the effects RBF has on expected time to seek care for women experiencing 
pregnancy related complications and the associated household costs. Other factors that may 
independently influence time to seek care and household costs are also discussed. 
8.1 Social-demographic features of household surveys participants  
A total of 5,622 women were surveyed across the three time points: baseline (2013), 
midline (2014) and endline (2015). Table 10 illustrates the social-demographic features 
and care seeking patterns for the 2,219 (39.4%) women who reported a complication 
stratified by the year of survey and group (RBF or non-RBF). Of these, 1,716 (30.5%) 
sought care, out of which 691(12.2%) were treated as in-patients. Across the sample, the 
mean age ranged from 24.8 to 26.0, most of the women (66.7-75.0%) had given birth more 




Compared to the RBF group at endline, there were significantly fewer married 
women (82.3 vs 89.1%) but more women heading households (13.6 vs 6.2%) in the non-
RBF group. Although there was suggestive evidence that care seeking for reported 
complications was low among women in non-RBF group at baseline and midline, these 
differences were not statistically significant. In both RBF and non-RBF facilities, care 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































8.2 Household costs associated with pregnancy related complications 
care 
Table 11 shows that women reporting a complication incurred similar mean costs at 
baseline and midline. Mann-Whitney test showed that the median costs were not 
significantly different between the women in RBF and non-RBF groups across the surveys, 
although the mean costs were high for the women in the RBF group at endline. The total 
costs incurred by women who received in-patient care across the surveys are shown in 
Table 12, stratified by facility type within each group as resource use may differ by level 
of health facility. Women admitted for in-patient care at BEmOC facilities had higher mean 
costs than women admitted for care at CEmOC health facilities. There was no significant 
difference in the median costs incurred by the women between the two groups. As a 
percentage of total costs, transport/other costs (i.e. food and accommodation) and 
productivity losses separately accounted for nearly 50% of all costs for both RBF and non-



















































































































   
   

























































































































































































































































































































   















   
   
   
















































































































































































































































































































































































































































































































































8.3 Effects of RBF on household costs associated with pregnancy 
related complications care.  
Regression analysis showed that the expected mean costs for obstetric 
complications were not significantly different between women who received RBF and 
those who did not, at both midline (1 year after RBF implement nation) and endline (2 
years after RBF implementation). This was the case both for all women seeking 
complication care (the full model) and when only women who ended up admitted for in-
patient care were included (restricted model) Table 13. The full model showed significant 
negative associations between costs and parity, women heading households, registration 
for CCTs and being middle poor. It also showed significant evidence of positive association 
between cost and increasing number of in facility days and between costs and in-patient 
care, the proxy for complication severity. The expected mean costs increased by 7.8% 
(95% CI:6.1-9.6) for each additional day in a facility and was 945.4% (95%CI: 843.7-
1,058.8) greater for women who received in-patient care compared to those who did not. 
In the restricted model associations were similar, except that heading household and being 
middle poor status were no longer significantly negatively associated with costs, while 









Table 13: Effects of RBF on household costs, adjusted for covariates 
 Full costs model: N =1,716  Restricted costs model: N=691 
  Coefa 95% CIb       Coefa          95% CIb 
Year1*RBF -.047 -.414 .319  -.018 -.718 .680 
Year2* RBF .270 -.221 .762  .431 -.358 1.221 
 
   
 
   
Age .001 -.004 .007  .014 -.008 .036 
Parity -.073 -.127 -.019  -.206 -.218 -.194 
Married -.085 -.312 .140  -.129 -.314 .055 
Heads Household -.106 -.172 -.041  -.327 -.672 .017 
Educated .049 -.129 .227  .181 -.071 .434 
Residence -.263 -.583 .056  -.467 -.882 -.051 
Distance -.001 -.017 .013  -.003 -.010 .002 
Facility .066 -.152 .286  .018 -.119 .156 
Registered -.203 -.318 -.087  -.501 -.818 -.183 
Days .075 .059 .092  .069 .061 .078 
In-patient 2.34 2.244 2.450     
SES        
Middle -.063 -.112 -.015  -.220 -.590 .148 
Least poor -.006 -.194 .182  -.109 -.815 .596 
 
   
 
   
Constant  6.220 5.805 6.635  8.178 7.708 8.648 
aCoefficientb95% Confidence interval  
8.4 Time to seek care for pregnancy related complications 
Table 14 illustrates that at baseline and midline, the median duration to seek care 
was not statistically different for women with self-reported complications between the RBF 
and non-RBF group. However, women in the RBF group took significantly less median 

































































































































































































































































8.5 Effect of RBF on time to seek pregnancy related complications 
care.  
Regression analysis showed that the expected mean time taken to seek 
complications care was significantly lower for women who benefited from RBF compared 
to women who did not. This was the case both for all women seeking care for reported 
complications (the full model) and when only women admitted for care were included 
(restricted model). In both models, the estimated effects were much stronger in the second 
year of program implementation Table 15. In the full model, women in the RBF group in 
year 1 took 27.3% (95% CI:28.4-25.9) less while in Year 2 they took 34.2% (95%CI: 37.8-
30.4) less time to seek care compared to women in non-RBF group. In the full model, time 
was significantly positively associated with increasing age, being married and registration 
for CCT whereas parity, education and in-patient care (disease severity) were significantly 
negatively associated with time. Women who ended up admitted for in-patient care took 
significantly less time to present for care,63.7%(95%CI: 73.9-49.5), than women with 
reported complications but who were not admitted for care. The decision to admit women 
was based on clinical assessments and largely based on complication severity. This finding 
therefore means that women who experienced severe complications in the intervention 
group on average took much less time to present for care.  
In the restricted time model, being married was the only attribute significantly 
positively associated with time, while age, education, distance and middle poor were 













Table 15: Effects of RBF on time to care (days) for obstetric complications, adjusted for covariates 
 Full Time Model: N=1, 716  Restricted Time Model:  N=691 
 Coef.a 95% CIb  Coef.a 95% CIb 
        
Year1* RBF -.318 -.335 -.300  -.458 -.568 -.348 
Year2* RBF -.419 -.476 -.363  -.835 -1.084 -.585 
 
   
 
   
Age .010 .004 .015  -.016 -.024 -.009 
Parity -.083 -.102 -.064  -.293 -.341 -.245 
Married .135 .038 .233  .697 .468 .926 
Heads Household .101 -.057 .260  .325 -.196 .848 
Educated -.200 -.295 -.104  -.602 -.829 -.374 
Residence .170 -.030 .370  -.392 -.886 .102 
Distance .013 -.014 .040  -.016 -.028 -.005 
Facility -.057 -.224 .109  .391 -.150 .933 
Registered .166 .101 .231  .397 -.136 .931 
In.patient -1.014 -1.344 -.684     
SES    
 
   
Middle .044 -.142 .231  -.289 -.457 -.121 
Least poor .065 -.004 .136  -.140 -.497 .215 
 
   
 
   
Constant  .906 .770 1.041   .135 .020 .250 
aCoefficient 
b95% Confidence interval  
8.6 Study limitation 
This study has several limitations which merit discussions as they may affect how 
the results are interpreted. The limitations mainly relate to study design, outcome 
measurements and intervention implementation.  
8.6.1 Study design limitations 
Randomized controlled trials (RCT) are the ‘gold standard’ when the purpose of a 
study is to generate convincing evidence on the effect of an intervention (Rychetnik, 
Frommer et al. 2002).  However, for practical reasons, public health interventions like RBF 
can rarely be studied using RCT designs. In this case, a pre-post design with controls was 




outcome of interest is influenced by the intervention, this design does not have control over 
unobservable or omitted variables that may also be changing at the same time the 
intervention is implemented (Thiese 2014), making it challenging to fully attribute 
observed changes in outcomes to the intervention. In this study, selection of variables to 
include in the models was based on the literature and to control for omitted variables, as 
many covariates as were available from the datasets were included. Still, it is plausible that 
other potential covariates were not included, which may have biased the results. 
A key identifying assumption in econometric analysis aimed at assessing 
intervention effects is that of parallel trends. That is, the average change in the control 
groups represents the counterfactual or change in intervention groups in the absence of 
treatment. While the  difference-in-differences method appears  preferred  for analysis of 
RBF impact (see for example (Bonfrer, Soeters et al. 2013, Binyaruka, Patouillard et al. 
2015)), it was deemed not suitable in this study because the dependent variables were very 
skewed. If more than one data points were available before the intervention, it would have 
been possible to verify this assumption empirically. In the absence of such data points, the 
estimating specification for both dependent variables (time and costs) included time trend 
differentials (year dummy variables) between the control and intervention groups at least 
to control for yearly trends.  
8.6.2 Outcomes measurement limitations 
Pregnancy complications were self-reported. Although attempts were made to 
verify the diagnosis by checking formal diagnosis in the health passports or discharge slips, 
this was not possible for the majority of women (about 60%). If these women had minor 
ailments, that would bias the cost estimates downwards and the time estimates upwards, 
on the assumption that household may not seek care early if they perceive a condition minor 
or not urgent.  
 Not all women sought care for their self-reported complications. The women who 
did not seek care could thus bias the results, if the selection into care was different in areas 




service use between the RBF and non-RBF across the survey years, a large selection bias 
should not be anticipated.  
Because the information from the study participants was collected retrospectively, 
recall bias resulting in time-varying deferential reporting of study outcomes may have 
affected the results. Although this could have affected any of the variables e.g. 
complications service use or type, this would especially be relevant for the dependent 
variable, cost, given reported problems for respondents to remember expenditures and 
incomes when the reference period is too long (up to 12 months in this case) or if the 
expenditures are not disaggregated enough. Less disaggregated expenditures tend to 
underestimate expenditures(Beegle, De Weerdt et al. 2010).   As a four-week recall is often 
used in cost studies (Deaton and Kozel 2005), we compared costs/ time estimates reported 
within 4 weeks of termination of pregnancy with those reported after 4 weeks as validation 
checks and to assess size of bias, if any. We made these comparisons between the two 
groups, before and after the implementation of RBF. The results (not shown) demonstrated 
no influence of recall bias on time estimates (the null hypothesis that time estimates 
between the two time periods were not different could not be rejected) but suggested recall 
bias may have affected cost estimates in the post RBF period (costs estimates tended to be 
higher within 4 weeks period for both RBF and non-RBF group when compared to the 
period after 4 weeks).  
Finally, the study may have suffered from social disability bias (Grimm 2010). The 
women in study areas for example may have over reported expenditures hoping the 
program would offer higher financial rewards. 
8.6.3 Intervention implementation  
In the dicussions above, fidelity of the evaluation process  to detect the success or 
failure of the RBF intervenion to effect changes in outomes of interest was considered. In 
this section,  the intervention itself is considred, based on the premise that the success or 




The operation definition of exposure in the study was receipt of PBF and CCT. As 
noted in section 4.6, programtic challenges entailed that the two components were 
staggered, wth the CCT component only becoming fully functional towards the end of 
2014. The implication is that there was heterogeneity in exposure for the women in 
intevention areas. In an attempt to ascertain the separate effects of  CCT, a dummy variable 
equal to 1 if women were registered for CCT and 0 otherwise was created and included in 
the GLM regressions.  Because the CCT group was a subset of the intervention group, there 
was concern this may have induced collinearity problems. Routine diagnostics however 
showed collinearity not to be a severe problem.  
8.7 Discussion 
This study increases our knowledge on RBF since it is the first to describe costs and 
time to seek care for reported obstetric complications within the context of RBF. RBF 
substantially reduced time to seek care for women experiencing a pregnancy related 
complication, while RBF did not produce any substantial effect on related household costs.  
8.7.1 Costs of obstetric complications care 
RBF did not have any substantial effect on household costs among women with 
reported pregnancy related complications. In settings like Malawi where MNH services are 
free, it may be difficult for RBF to produce a significant effect on household costs related 
to seeking care when both direct and indirect costs are considered together. The finding 
that indirect costs were significantly lower for households that benefitted from CCT 
indicates that RBF has potential to reduce overall economic burden on the households,  
Overall, relative percentages for different cost sub-categories were similar between 
women in RBF- and non-RBF areas. The results  are consistent with findings  by McIntyre 
et al (McIntyre, Thiede et al. 2006), showing that other direct costs (e.g. transports, food) 
and indirect costs are substantially higher than medical costs alone, which is not surprising 
given that Malawi does not impose formal user fees. The finding on reduced expected mean 
costs and substantially reduced informal caregiver engagement (results not shown) among 




informal caregivers’ time or support.  The few informal caregivers per case among 
beneficiary households allow them to minimise productivity losses sufficiently to lower 
overall household costs.   
8.7.2 Time to seek obstetric complication care 
The mean time to seek care for obstetric complications was significantly lower for 
women exposed to RBF intervention. This effect was stronger in the longer rather than 
shorter term.  This finding is similar to that published by Nahar et al (Nahar, Banu et al. 
2011) in Bangladesh showing that  financial reimbursements were associated with reduced 
delays in seeking emergency obstetric care, though this work was not done within a formal 
RBF context. 
Several possible explanations may underlie the observed reduction in time to seek 
care in the study setting. Supply side improvements in quality of care may have occurred 
in RBF facilities, inclining household decision making towards early care seeking. The 
promise of transport refunds may have emboldened beneficiaries to increase fiscal 
expenditure thresholds, allowing them to use relatively expensive, but quick modes of 
transport, to get to facilities. Alternatively, the prompt care seeking noted in RBF areas 
could have been part of a response to broader health education/promotion efforts in the 
areas informing women about obstetric dangers signs and encouraging them to seek formal 
care early, or a more functional referral system may have existed in intervention areas. 
Below, each of these plausible explanations is examined in turn. 
First, there is consensus that quality health services attract women to formal care 
(Andaleeb 2001, Brighton, D'Arcy et al. 2013, Srivastava, Avan et al. 2015).  Parallel  
project evaluations provided evidence of attendant improvements in structural quality for 
RBF facilities as a result of equipment and other supplies provided as part of RBF4MNH 
to strengthen facility capacities (Brenner, Wilhelm et al. 2017). Because the  majority of 
women in the RBF areas at least attend one antenatal care visit (Mazalale, Kambala et al. 
2015), it is probable that engagement with better antenatal care services during preceding 




at intervention facilities, leading to subsequent prompt care seeking in times of potential 
obstetric emergencies.  
Second, guarantees of transport refunds could have empowered potential 
beneficiaries to use their fiscal resources to pay for motorized modes of transport. 
Alternatively, guarantees of cash refunds could have reduced perceived financial 
constraints allowing household to take immediate decisions to seek emergency obstetric 
care. Regarding the former, study data does not support this assertion as the percentage of 
households that used any motorized form of transport (e.g. cars) did not significantly differ 
between RBF and non-RBF areas (results not shown). Women registered for CCT had 
significantly higher expected mean time to seek care, which does not support our premise 
that perceptions of fiscal empowerment may have promoted prompt decision making.  
Third, health education is an integral part of RH services provided to antenatal 
women. Centrally planned and coordinated, standardized reproductive health education is 
evenly provided across all facilities in a district. Although local non-governmental 
organizations are increasingly taking part and supporting DHMT in health promotion 
activities in the study districts, there is no evidence that intervention areas received any 
special intensive health promotion activities. In fact, the data shows that care seeking 
patterns were not different between RBF and non-RBF groups Table 10. Fourth, even 
though referral systems were not explicitly incentivised, there is a possibility that 
(presumably) motivated health providers in intervention BEmOC facilities could have 
coordinated better with CEmOC facilities to arrange transport for the women with 
complications, for those referred from BEmOC to CEmOC facilities. There is evidence 
that differential transport arrangements existed between intervention and control facilities, 
but this was in favour of referrals from control BEmOC (Brenner S and De Allegri M 
2015).   
Ruling out these alternatives, I conclude that the significantly reduced time to seek 
care observed in intervention areas most likely resulted from prompt decision making at 
household level due to perceptions of facility quality improvement, while community level 




From a policy perspective, it is important that women with higher risk profiles for 
obstetric complications (e.g. high parity or the poor) present for curative care early. It is 
therefore worth exploring how responsive women with different risk attributes were to 
RBF. I found that high parity, education, increasing distance and medium poor status were 
associated with significantly lesser expected mean time to seek care. The experience that 
comes with more births (high parity) and information associated with high education 
allows women to make better decisions as might be expected. That the medium poor 
respond faster than the poor reiterates the usual disadvantage faced by the poor while 
underscoring the need to formulate interventions that explicitly target the poor 
It is a fair question to ask what influence different components of RBF4MNH had 
on primary study outcomes. The observed short-term effects give an estimate of what to 
expect if only supply-side incentives were in place; a significantly reduced mean time to 
care but no substantial change in overall household costs. Unfortunately, estimating with 
certainty any additional effects accruing from a combination of supply and demand-side 
incentives is not possible in our study given the low coverage (25%) for demand-side 
incentives.  Because this would be valuable information for policy makers, studies based 
on optimally designed and implemented RBF programs that allow for such detailed 
evaluations are needed. Information on relative effectiveness of RBF components will 
provide more policy options: enabling better configuration of financial incentive structures 
to align with local health priorities and health systems capacities. 
8.8 Conclusion 
The most important finding of this study is the significant reduction in the expected 
mean time taken before presenting for obstetric complication care by recipients of RBF. 
This occurred despite the lack of a substantial change in overall household costs. This result 
is probably a manifestation of the RBF induced quality improvements which encourage 
women to seek early care for pregnancy related complications. These results provide 




emergency care seeking and thus ultimately reduce maternal morbidity and mortality in 
beneficiary populations.  
CHAPTER 9: What is the cost-effectiveness of RBF?  
This chapter draws on findings from study III described in section 6.3. The chapter 
provides cost-effectiveness estimates for the Malawi RBF (PBF+CCT) initiative in terms 
of cost per death averted and life years gained when compared to input based funded 
maternal care. Key factors influencing RBF cost-effectiveness estimates are also described.  
9.1 Costs of RBF 
The estimated annual operational cost for an RBF facility was $53,774, about four 
times the costs for a non-RBF facility. The extra costs were largely RBF related, driven by 
new medical equipment investments, financial rewards and program monitoring. But, RBF 
facilities were also large in terms of catchment areas size and staffing levels.  RBF facilities 
also had higher non-RBF related budget lines e.g. salaries Table 16. A health worker in 
RBF facility received $420 annually as rewards, an amount that varied by health worker 
cadre. The professionals, e.g. nurse-midwives received almost three times as much rewards 
compared to non-professionals such as community health workers. Eligible mothers 
received $6 on average, over 50% of which was for reimbursing costs directly linked to 













Table 16: Facility characteristics and provider economic costs (US$) 
                  RBF non-RBF 
Number of sampled Facilities  2 2 
Catchment area population/ facility 23 494 41 124 
Number of deliveries/ facility/ year 1 212 1 506 
Number of Health workers per facility  30 26 
Professionals e.g. Nurses per facility  5 4 
   
Fixed costs per year/facility   
Building rentals 2 861 2 700 
Office furniture  240 232 
Salaries 9 339 6 281 
MoHa Medical Equipment 1 977 1 367 
RBF renovations/maternal shelters 8 894  
RBF Medical equipment 2 306  
RBF Training & Capacity building  2 454   
Subtotal fixed costs 28 071 10 579 
   
Variable costs per year/ facility    
Supplies  1 027 579 
Drugs 1 914 1 571 
Utilities & maintenance 1 436 675 
Transport  474 687 
RBF IECb 266  
RBF Supervision 2 829  
RBF Health worker incentives  12 577  
RBF Mother incentives 5 181  
Subtotal variable costs 25 703 3 511 
   
Grand total   53 774 14 090 
aMoH-Ministry of Health      bIEC-Information, education and communication.  









Table 17: RBF related incentives (US$) 
  
RBF Incentive per HW/ year  420.99 
        For professionals, e.g. nurse/ year 576,07 
        Others e.g. Community health worker/ year  197,9 
  
RBF incentive per eligible woman 5,77 
          Transport 0,55 
           Delivery  3,00 
          48 Hour stay  2,21 
 
RBF- Results-based financing.    HW: Health worker 
Source: Author calculations 
9.2 Cost-effectiveness of RBF relative to non-RBF 
The model estimated that compared to non-RBF, each additional birth costs $42.83.  
Taking both maternal and perinatal deaths into account, RBF would avert one additional 
death and gain one additional life year at an incremental cost of $29,135 and $1,045 
respectively, Table 18. 
Table 18: Incremental cost effectiveness ratios of RBF compared to non-RBF, by outcomes 
 RBF non-RBF   
              Mean                                      Mean Incremental   
 Outcome Costs ($) Effects Costs ($) Effects Costs ($) Effects ICER ($)a 
Deaths  55.55   0.055 12.72 0.057 42.83 0.0015           29,135 
LYGb  55.55 51.343 12.72 51.302 42.83 0.0410 1,045 
a Incremental cost effectiveness ratio, estimates by TreaAge software,  b Life years gained (discounted). 
9.2.1 One-way sensitivity analysis  
The ICERs for any life year gained were sensitive to changes in coverage of RBF facility-
based births and the share of women accessing quality care (effective coverage) in non-
RBF facilities Figure 17. For example, a 10% change in RBF facility births or births in 
non-RBF facilities with quality care would lead to a 25% and 30% change in ICER, 




with most relative influence on RBF cost-effectiveness are shown in Figure 17. 
 
 
Figure 17: One-way sensitivity analysis showing variations in incremental cost-effectiveness ratios per life year 
gained. 
 
RBF-Results based financing. EmOC-Emergency obstetric care. CFRs-Case fatality rates.  
9.2.2 Probabilistic sensitivity analyses  
The ICER scatter plot illustrates that all iterations of LYG in the RBF relative to 
non-RBF arm consistently have positive costs, reflecting higher relative RBF costs with 
certainty. However, some iterations have less (negative) LYG relative to non-RBF, 
suggesting that the probability of overall lower health effects in the RBF arm relative to 






Figure 18: Incremental cost-effectiveness scatter plot for RBF relative to non-RBF 
The probabilities that RBF is cost-effective compared to non-RBF at different levels 
of willingness to pay are shown in Figure 19. At a willingness to pay of $1000 per life 
year gained, RBF and non-RBF have equal probabilities of being cost-effective. With 
lower willingness to pay for health, non-RBF is most likely to be optimal, while for higher 
levels of willingness to pay RBF represents the policy most likely to be optimal. At 






Figure 19: Cost-effectiveness acceptability curves for RBF compared to non-RBF funding option 
9.3 Model validation 
MacCabe and Dixon have proposed four dimensions for assessing validity of cost- 
effectiveness models: (i) the structure of the model (ii) the inputs of the model (iii) the 
results of the model  and (iv) the value of the model to the decision maker (McCabe and 
Dixon 2000).  They raise doubt if   a set of objective tests of validity will ever be produced.  
The model was validated based on its results, which arguably is objective. The model 
estimates a perinatal mortality rate of 49/1,000 births in the baseline scenario, which is 
very comparable to 56/1,000 births reported for the SSA region and the 40/1,000 births 
estimate for Malawi (National Statistical Office 2010).  
Model structure and key inputs to the model are discussed below under limitations 




9.4 Study limitations.  
This study has several limitations. They include model input parameters, data 
collection and methodology or frameworks used. 
9.4.1 Input for effectiveness 
 The parameter estimates of RBF “effects” on stillbirth and maternal case fatality 
rates were based on program evaluations results from Zambia and Uganda due to lack of 
randomized trial data.  Pre-post program evaluations do not have the rigor of clinic trials 
about bias control or minimization. The implication is that one cannot be fully certain of 
how biased the “effects” estimates used for the study are or, ultimately, the actual impact 
RBF has on perinatal and maternal mortality. It’s worth noting that new program like the 
one in Zambia and Uganda tend to be closely supervised. Thus, intense monitoring and 
supervision under program settings may have improved program effectiveness, biasing the 
effect estimates downwards. An attempt to minimize this was made by using mean 
effectiveness estimates in the baseline scenario. Moreover, to characterize these 
uncertainties, wide ranges (±20%) in probability sensitivity analysis were used and the 
main results were found to be stable across the ranges. 
9.4.2 Data collection limitations 
It was not possible to account for maternal deaths that occurred before 28 weeks 
gestation due to lack of data. Because the share of maternal deaths before 28 weeks is small 
and as early maternal deaths are not explicitly targeted by RBF, they may be assumed to 
be a constant that does not affect study estimations. Thus, this omission is less likely to 
substantially bias the effectiveness estimates. 
 Even though the initial hope was to estimate costs from societal perspective, which 
entails inclusion of all costs and benefits associated with an intervention, not all costs were 
captured.  In particular, it was not possible to reconstruct start-up costs incurred during 
RBF program planning/design at central levels. This might have led to underestimating 





9.4.3 Limitations related to methodology or frameworks 
 The remaining three limitations relate to methodology or frameworks used in the 
study. Although decision-analytical models are increasingly being used to evaluate health 
polices to guide resource allocations, they have limitations. Relevant to this study is their 
limited ability to account for long term health outcomes such as chronic sequelae of 
preganancy related complications. Although in theory it is possible to add branches to a 
decision tree to allow for this, the results may be a more complex model possing more 
challenges finding reliable input data. Also, decision tree models are not good at modeling 
repeated events (and for individual women, pregnancy episodes are). Other modelling 
approaches, such as Markov models, would have been more suitable to handle such 
scenarios. While it was initially hoped to use Markov models to overcome some of these 
limitations, in practice,  lack of quality data to parametrize the models compelled us to 
settle for decision tree models.  
A narrow RBF framework,  which emphasizes payments based on outputs verified 
for quality,  provided a good basis to study costs and effects of RBF as considered within 
this thesis. However, others have question whether this narrow definition corresponds to 
reality (Renmans, Holvoet et al. 2017), given that in developing country settings the 
implementation of financial incentives based on performance often is not a standalone 
intervention. It involves a broader set of reforms geared towards strengthening the health 
systems including providing more autonomy and enhancing health information 
management (Witter, Toonen et al. 2013). In using this narrow RBF framework, an implicit 
simplifying assumption was that all RBF effects can be measured as health outcomes.    
Finally, there are limitations of CEA framework which may have affected the 
results. This primarily relates to the lack of CEA to capture more dimensions of health 
status, pertinent for a complex intervention like RBF initiative in Malawi (acting at 
different levels through the continuum of pregnancy related care). As already alluded to 
previously, cost utility analysis would have been a better option. Using cost utility analysis 
would have at least allowed incorporation of qualitative health outcomes and might have 





This study demonstrates that an RBF intervention (PBF +CCT) with a strong quality 
improvement component is probably cost-effective compared with input based financed 
maternal and perinatal care.  These results were achieved in a situation of high levels of 
facility-based delivery and in the absence of significant changes in service use, 
underscoring the potential gains for maternal and new-born survival due to RBF induced 
quality improvements.  
To the best of my knowledge, this is the first full economic evaluation of a RBF 
(PBF+ CCT) intervention to address MNH in a low-income country.  Thus, there are no 
obvious previous studies against which these results may be compared. For a voucher 
program aimed at increasing facility births in Uganda, Alfonso et al have reported an ICER 
per maternal death averted of $20,756 (Alfonso, Bishai et al. 2013).  This estimate however 
ignores the benefits in terms of perinatal health, as they were not included in the benefits 
estimations. Hounton et al assessing a health worker surgery training aimed at increasing 
access to EmOC in Burkina Faso have  reported an ICER per perinatal death averted of 
$11,757 (Hounton, Newlands et al. 2009).  But this estimate ignores maternal health 
benefits which were not included in the calculations of the health benefits. We find higher 
ICERs than the two above mentioned studies, even though we included both maternal and 
perinatal health benefits in our estimations. This may in part be explained by higher 
investments costs associated with PBF schemes (Borghi, Little et al. 2015), a key 
component of the Malawi RBF intervention. In addition, the study RBF facilities tended to 
have higher catchment areas and staff sizes (study II), the possibility that high operational 
costs in Malawi RBF facilities may in part underlie the observed high ICERs can therefore 
not be excluded.   
Because the RBF intervention appears more effective, but also more costly than 
providing emergency obstetric care under status quo conditions, decisions to adopt it would 
depend on policy makers’ willingness to pay. At a willingness to pay of $1,146 per LYG, 
(3 times Malawi GDP per capita) policy makers can be 60% certain that RBF is cost-




effectiveness. As others have noted, the choice of a new intervention is not only based on 
cost effectiveness analysis (CEA) results alone, but also on the capacity of resource-
constrained governments to sustain its routine use (Marseille, Larson et al. 2015). A 
pertinent question to ask is whether the health system in Malawi will sustain the RBF 
program and sustain its operations when external financial assistance ceases. While this 
thesis did not focus on this area, moving forward, an important line of inquiry would be to 
conduct budget impact analysis of RBF. Such inquiry will provide information on RBF 
affordability and the potential for the government of Malawi to finance RBF using 
domestic sources.  
A key challenge facing health systems in SSA is the persistence of coverage gaps 
in other vital MNH interventions. The implications for low income SSA countries like 
Malawi of implementing new costly interventions based on the WHO threshold should 
therefore be carefully considered. Within the framework of opportunity cost or budget 
constraint, introduction of a new program can only occur at the expense of pushing other 
interventions out. If  the interventions being replaced have more returns at the margin, this 
would  risk lowering overall population health attainment and increasing health inequalities 
(Revill, Walker et al. 2014). Again, this underscores the need for additional analysis 
beyond economic evaluations: they may also offer needed insight regarding broader impact 
of RBF on health systems or other interventions. 
The model is sensitive to estimates of coverage of RBF facility births and the 
proportion of births in non-RBF facility with good quality care. Quality of care is important 
in healthcare including RBF programs and there are ongoing efforts to improve its 
measurement and reporting (Brenner, De Allegri et al. 2015). The observed sensitivity 
underscores the importance of quality as it relates to health outcomes and that better data 
are needed to improve our model accuracy. Though the model is sensitive to the share of 
births in RBF facilities, it is not sensitive to the percentage of complications among facility 
deliveries (FD). The share of complications among FD depends on coverage of facility 
based deliveries since women with complication self-select into care, especially when FD 




SSA, ranging from as low as 12% in Ethiopia (Yesuf, Kerie et al. 2014) to as high as 91% 
in Malawi (Mazalale, Kambala et al. 2015), we postulate  that cost-effectiveness of RBF 
may be strongly influenced by the share of obstetric complications at much lower FD rates 
than those obtained in Malawi. In this regard, CEA studies in different setting are required 
to contextualize findings. The lack of demonstrable sensitivity of ICERs to RBF costs is 
surprising, given the financial outlays associated with RBF (Mayora, Ekirapa-Kiracho et 
al. 2014).  
This study did not consider benefits from potential reductions in maternal and 
perinatal morbidity due to lack of quality data. Studies on MNH report a heavier morbidity 
burden due to disabilities than to mortality per se (Adeoye, Onayade et al. 2013). Inclusion 
of averted morbidity would thus increase effectiveness and improve cost-effectiveness of 
RBF. Future CEA studies should account for the potential of RBF to reduce disabilities 
(Mangham-Jefferies, Pitt et al. 2014).  
Large differences in rewards based on cadre were observed. The size of financial 
rewards is assumed to positively influence performance (Franco, Bennett et al. 2002) while 
perceived unfairness in distribution of rewards may de-motivate staff, undermining RBF 
objectives. Assessment of adequacy of rewards, perceived fairness in how rewards are 
shared and their impact on health system performance should inform future lines of 
inquiries. 
9.6 Conclusion: 
At high levels of willingness to pay (3 times Malawi GDP per capita), RBF appears 
a cost-effective way to fund health facilities to improve quality of maternal and perinatal 
health, and to fund pregnant women in order to increase access to emergency obstetric care, 
compared to the current non-RBF based funding. At this level, RBF cost-effectiveness is 
also comparable to other RBF interventions currently implemented for maternal and 
perinatal survival in the SSA region. However, at less than 3 times Malawi GDP per capita, 
RBF is less likely to be cost-effective, implying that RBF implementation at this threshold 




benefits at health system level. These considerations underscore the need for countries to 
carefully consider broader health systems RBF benefits before its implementation. 
Although economic costs of running RBF-supported facilities are about 4 times as 
expensive compared to costs at facilities without RBF, the intervention averts 3.5% deaths 
occurring in the status quo MNH care in Malawi. The cost of $1,046 per life year gained 
is lower than three times Malawi’s GDP per capita, which is commonly suggested as a 
decision rule for implementation.  
This is the first cost-effectiveness study of an RBF (PBF+CCT) intervention in 
Africa south of the Sahara and many unresolved issues remain.  More RBF CEAs are 
merited to explore cost-effectiveness of different intervention types, different health 
systems settings and health services, and to reduce uncertainties around RBF CEA 
estimates related to modeling. Researchers in SSA should take advantage of the numerous 
RBF studies being implemented in the region to generate needed economic information to 
support policy decisions. RBF studies should prioritize generating better health outcomes 
data. Future economic evaluations should focus on identifying optimal RBF designs and 
implementation models that have lower transactional costs. They should also assess 
adequacy of different reward options and fairness of allocation mechanism that maximize 
individual health worker and team efforts.   
CHAPTER 10: Summery of main findings and 
recommendations  
10.1 Key findings 
The first objective of this thesis was to assess the benefits of institutional-based 
births compared to home deliveries in terms of reducing the risk of maternal and perinatal 
mortality among pregnant women in the SSA region. This study found that the risk of 
perinatal deaths is lower for institutional births relative to home births while the risk of 
maternal mortality is high among institutional births relative to home births, possibly 




The second objective was to assess the effects of RBF on time to seek care for 
pregnancy related complications and associated costs households incur during obstetric 
emergency care seeking.  This study found that among pregnant women, receipt of RBF 
was associated with substantially reduced expected mean time to seek emergency obstetric 
care.  This effect was greater in the longer than shorter term. Time to seek care was 
positively associated with increasing age, being married and registration for CCT while 
parity, education and disease severity were negatively associated with time to seek care. 
No substantial change in overall household costs was found between households in 
RBF compared to households in non-RBF areas. Household costs were significantly 
positively associated with increasing number of days spent in a facility and with in-patient 
care treatment, the proxy for complication severity. Household costs were significantly 
negatively associated with parity, women heading households, registration for CCT and 
being middle poor.  Women who registered for CCT had substantially less engagement 
with informal caregivers during illness episodes, leading to significantly lower expected 
mean costs among the women’s overall households’ costs.  
The third objective was to assess the cost-effectiveness of RBF compared to the 
status quo. This study found that RBF is probably cost effective at a conventional although 
ambitious threshold for willingness to pay. Importantly, RBF cost-effectiveness is 
comparable to contemporary interventions used to promote maternal and neonatal care in 
the region.  
10.2 Public health implications and recommendations  
The thesis findings provide information which answers important public health questions.  
 The results suggest that institutional based deliveries are beneficial in reducing 
perinatal mortality in the sub-Saharan Africa relative to home births. Women, 
especially the poor, should therefore be encouraged and supported to give birth in 
health facilities.  
 The data shows that there is increased risk of maternal mortality in health facilities 




institutions in the SSA region to drive down the high maternal mortality rates 
currently observed. Importantly, quality improvement efforts should precede and be 
prioritized over efforts to increase institutional based births, especially in settings 
like Malawi where facility births are already high. 
 The finding that RBF is associated with reduced expected mean time to seek care 
has the potential to lead to improved promptness of health facility attendance for 
women with pregnancy related complications, which may result in better outcomes 
(if quality care is provided) and reduced obstetric emergency related care costs on 
households.  
 Households of women with pregnancy related complications face high indirect costs 
relative to medical costs even when provided with financial support.  Alternative 
interventions that lower such indirect costs are therefore needed as they may reduce 
the economic burden of treatment and make households resilient to health financial 
shocks due to maternal or perinatal complications. 
 RBF (PBF+ CCT) is probably cost-effective at high thresholds of willingness to 
pay. Countries in the SSA region should carefully consider broader health systems 
benefits when deciding to implement RBF as one of the tools to improve quality of 
care and reduce maternal and perinatal mortality in health facilities.  
10.3 Research implications 
The studies presented within this thesis expanded our understanding and knowledge 
of benefits of facility-based births in the SSA region, the effects of RBF on timeliness to 
seek care for pregnancy related complications and associated household costs. Additional 
knowledge related to cost-effectiveness of RBF and its key drivers in the region was also 
provided. However, further research is suggested as many questions remain unanswered.  
The first relates to measures of maternal and perinatal intervention effectiveness in 
terms of morbidity and mortality reductions. Such measures should be prioritized instead 
of the commonly used intermediate indicators, for instance, facility-based delivery rate. To 




in developing country settings will be important. This will enable better tracking of 
intervention impact and directly support complimentary studies such as cost-effectives 
analyses and quality improvement assessments.  
Time to seek emergency obstetric care is influenced by multiple factors, including 
gender and power dynamics in the home. Qualitative studies are therefore needed to 
explore how RBF empowers women or affects decision making in the homes, particularly 
in developing countries where key health choices are made by men.  
Since RBF in Malawi and most countries in SSA is largely development partner’s 
supported, research is needed to assess the affordability and sustainability of RBF in the 
region. RBF continuity can only be guaranteed if domestic financial resources are adequate 
to finance recurrent operational costs beyond donor support.  
More RBF cost-effectiveness studies are needed in the SSA comparing efficiencies 
of different RBF designs and to reduce uncertainties surrounding current RBF cost-
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Appendix 2:  Informed consent form: Results based financing for maternal and 
neonatal health (RBF4MNH) 
 
 
                                                           
UNIVERSITY OF HEIDELBERG      UNIVERSITY OF   MALAWI      UNIVERSITY OF BERGEN 
 
Who is conducting the study 
This research study is being conducted by University of Malawi, College of Medicine, 
Malawi; University of Heidelberg, Germany and University of Bergen, Norway. It is being 
led by Professor Adamson Muula of College of Medicine, University of Malawi.  
What is the aim of the study 
In this study, we are looking at how well Results based financing (RBF) works. RBF is 
provided by the Ministry of Health in the following districts: Mchinji, Dedza, Ntcheu and 
Balaka. As part of RBF intervention, money is given to hospital staff if they provide 
selected services to pregnant mothers and the new-born according to agreed standards.  
Money is also provided to pregnant women who have given birth at health facilities and/ 
or have stayed in the facility for 48 hours after birth. In this study we would like to find out 
if the procedure of handing out cash to hospital staff and mothers who have recently given 
birth encourages or improves utilization of maternal health services by pregnant women in 
Malawi. Results from the study will help us give proper recommendations to the Ministry 
of Health on ways to improve service use and quality of maternal health services in Malawi.  
What are the study procedures? 
This study component looks at how RBF affects those who receive maternal and new-born 
health services. The Household survey interviews will be conducted with the mothers who 
have terminated a pregnancy in the past 12 months before the date of the interview. The 
questionnaire will be asked to both mothers who have benefited from RBF or not. The 
questionnaire will collect basic demographic information such as age, area of residence, 
marital status, ethnicity and religion. Information related to obstetric history will also be 
collection. This information will include but will not be limited to number of pregnancies, 
outcomes of pregnancies and place of birth. Questions specifically related to the last 
pregnancy will include use of antenatal services, place of delivery, experienced illnesses 
during the pregnancy, care seeking for any reported illnesses and costs associated with the 
care seeking. This questionnaire will take 45 to 60 minutes to complete. 
Risks associated with the study  





Please note that your participation in the research is entirely voluntary in all phases. If you 
don’t want to take part, you can refuse without any penalty or loss of benefits to you. If 
you do agree to participate and then change your mind, please tell the researchers and they 
will end your participation immediately, without any penalty or loss of benefits to you. 
You can do this at any point during this study.  
Cost or compensation to you for participation 
There are no costs or compensation to take part in this study.   
Confidentiality 
As a participant in the research you can expect that all the information you provide will be 
treated in confidence. This means that your name will not be used when we write our 
reports about the research. It also means that no one outside the research team will know 
how you as an individual answered the questions. We will not tell anyone at the College of 
Medicine or Ministry of Health about your responses.  No quotes or other results arising 
from your participation in this study will be included in any reports, even anonymously, 
without your agreement.  
Who approved this research: 
Ethical Committee of the Faculty of Medicine of the University of Heidelberg S-256/2012 
and the College of Medicine Research Ethics Committee (COMREC) (application number 
P.08/13/1438). 
Agreeing to take part in this research 
I have read the study information sheet and I understand what will be required of me and 
what will happen to me if I take part in it 
I understand that the information I will give will be treated in the strictest confidence.  
I understand that at any time I may withdraw from this study without giving a reason and 
that I will not be affected negatively in any way if I do not want to participate 
My questions concerning this study have been answered by _________________ 
I voluntarily agree to take part in this study 
Participant’s name (please print): ____________________ Date:_____________ 
 
Participant’s signature: ____________________ 
 
Or  
Participant’s thump print : ____________________ Date:_____________ 
Witness Name (please print): ____________________Date:_____________ 
Witness signature: ____________________ 
Re-searcher’s name (please print): ____________________ Date:_____________ 
Re-searcher’s signature: ____________________ 
More information 
For further questions about this research, your rights as a subject, or any adverse effects 






Malawi College of Medicine 
Community Health Department P.O. Box 360 
Chichiri, Blantyre 3. 
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